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Pharmacological modulation of mitochondrial calcium 
uniporter controls lung inflammation in cystic fibrosis
Alessandro Rimessi1,2*, Chiara Pozzato1, Lorenzo Carparelli1, Alice Rossi3, Serena Ranucci3, 
Ida De Fino3, Cristina Cigana3, Anna Talarico4, Mariusz R. Wieckowski5, Carla M. P. Ribeiro6, 
Claudio Trapella4, Giacomo Rossi7, Giulio Cabrini2,8, Alessandra Bragonzi3, Paolo Pinton1,2*
Mitochondria physically associate with the endoplasmic reticulum to coordinate interorganelle calcium transfer 
and regulate fundamental cellular processes, including inflammation. Deregulated endoplasmic reticulum–
mitochondria cross-talk can occur in cystic fibrosis, contributing to hyperinflammation and disease progression. 
We demonstrate that Pseudomonas aeruginosa infection increases endoplasmic reticulum–mitochondria associations 
in cystic fibrosis bronchial cells by stabilizing VAPB-PTPIP51 (vesicle-associated membrane protein–associated 
protein B–protein tyrosine phosphatase interacting protein 51) tethers, affecting autophagy. Impaired autophagy 
induced mitochondrial unfolding protein response and NLRP3 inflammasome activation, contributing to hyper-
inflammation. The mechanism by which VAPB-PTPIP51 tethers regulate autophagy in cystic fibrosis involves calcium 
transfer via mitochondrial calcium uniporter. Mitochondrial calcium uniporter inhibition rectified autophagy and 
alleviated the inflammatory response in vitro and in vivo, resulting in a valid therapeutic strategy for cystic fibrosis 
pulmonary disease.
INTRODUCTION
Cystic fibrosis (CF) is a genetic disease caused by mutations of the 
gene coding for the CF transmembrane conductance regulator (CFTR) 
protein (1). More than 2000 variants and 300 disease-causing muta-
tions have been identified thus far, with the deletion of phenylalanine 
at position 508 (Phe508del-CFTR) being the most common, affecting 
approximately 80% of patients with CF in Europe and the United 
States (2). Because of protein misfolding, Phe508del-CFTR is pre-
maturely degraded. In the lungs, the primary organ affected in CF, 
CFTR gene defects impair chloride transport, reducing water content 
in the airway surface liquid. This defect increases susceptibility to 
bacterial infections (such as those by Pseudomonas aeruginosa), re-
sulting in hyperinflammation and progressive pulmonary tissue 
damage, and leading to respiratory insufficiency (3). In addition to the 
lung tissue damage induced by the chronic inflammatory process 
itself, P. aeruginosa has been shown to compromise fundamental 
processes, including the immune response and the expression of 
rescued Phe508del-CFTR to the apical membrane (4). Thus, the pres-
ence of P. aeruginosa infection could exacerbate pulmonary CF 
pathophysiology and render recent CF therapies less effective. 
Therefore, alternative approaches aimed to activate early anti- 
inflammatory pathways to prevent organ damage before patients 
become symptomatic are needed (5).
Mitochondria have recently gained much attention in the medical 
field due to their involvement in several inflammatory-associated 
diseases, including CF. Perturbation of mitochondrial activity is 
sufficient to activate innate immune responses (6, 7), indicating that 
cells use mitochondrial stress to potentiate innate immunity programs 
when specific exogenous or endogenous stress alters mitochondrial 
homeostasis (8). The maintenance of functional mitochondria in cells, 
through mitochondrial stress response and quality control pathways, is 
thus essential to avoid exacerbation of the inflammatory response. 
A conserved lysosomal degradation pathway, called mitophagy, 
controls the quality of mitochondria in stressed cells, acting as a 
mitochondrial stress response together with the mitochondrial un-
folded protein response (UPRmt) (8). In relation to CF pathophysiology, 
a similar mechanism, called xenophagy, plays a role in sequestering 
and degrading invading pathogens, while macroautophagy controls 
CFTR intracellular trafficking and function (9, 10). Several protein 
complexes and signaling pathways, including Ca2+ signaling, are 
involved in these processes (11–13). However, whether Ca2+ signaling 
and autophagy are directly related to the CF lung–specific patho-
genic cascade remains unclear. Impaired Ca2+ homeostasis and au-
tophagic defects in CF have been reported, suggesting that both 
could be directly involved (7, 14–19).
We recently demonstrated that the degree and quality of the 
inflammatory response in CF bronchial cells are supported by 
P. aeruginosa–dependent mitochondrial perturbation, in which the 
mitochondrial Ca2+ uniporter (MCU) is involved in NLRP3 (NOD-, 
LRR-, and pyrin domain-containing protein 3) inflammasome acti-
vation and inflammatory exacerbation in vitro (7). Consequently, 
mitochondrial Ca2+ signaling represents a potentially useful but rela-
tively unexploited area for therapeutic innovation and intervention. 
From this viewpoint, the identified MCU is a strong candidate (20). 
The activity of MCU induces increases in mitochondrial Ca2+ con-
centration with defined timing, amplitude, and kinetics that affect 
mitochondrial activities, including adenosine triphosphate (ATP) 
production, inflammation, autophagy, and cell death (21, 22). How-
ever, mitochondrial Ca2+ homeostasis is primarily conditioned by 
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the close apposition of mitochondria to endoplasmic reticulum (ER) 
membranes, which regulates cell fate via inositol 1,4,5-trisphosphate 
receptors (IP3Rs) through voltage-dependent anionic channels 
(VDACs) and MCU (23). Miscommunication between the ER and 
mitochondria occurs in a number of degenerative- and inflammatory- 
related diseases (24); however, whether disrupted ER-mitochondria 
cross-talk is a consequence of the lung pathological conditions in 
CF remains elusive. ER-mitochondria contacts, also known as 
mitochondria-associated ER membranes (MAMs), are multiprotein 
platforms that appear to tether the two organelles regulating funda-
mental processes (24). The integral ER protein vesicle- associated 
membrane protein–associated protein B (VAPB) binds the outer 
mitochondrial membrane protein tyrosine phosphatase interacting 
protein 51 (PTPIP51) to form some of these tethers (25). By manipulat-
ing the expression of VAPB or PTPIP51, it is possible to modulate 
ER-mitochondria contacts, affecting interorganelle Ca2+ exchange 
and autophagy (26).
Here, we address the role of the MAM and VAPB-PTPIP51 tether in 
autophagy during P. aeruginosa infection in CF. We show that 
P. aeruginosa infection induces the increase of VAPB and PTPIP51 
expression in CF bronchial cells to stabilize ER-mitochondria asso-
ciation, thus affecting autophagy. We demonstrate that defects in 
CFTR channels lead to reduced selective autophagic clearance capacity 
during P. aeruginosa infection with consequence on mitochondria 
physiology, inducing persistent UPRmt and NLRP3 inflammasome 
activation and further down-regulation of the autophagic response 
and worsening of the inflammatory response in CF bronchial cells. 
We also show that the mechanism by which VAPB-PTPIP51 tethers 
regulate autophagy in CF cells involves their key role in mediating 
interorganelle Ca2+ transfer from the ER to mitochondria via MCU. 
This led us to hypothesize that KB-R7943, an inhibitor of MCU, 
could be beneficial for alleviating the P. aeruginosa–dependent 
inflammatory response in CF in vitro and in vivo. We show that 
KB-R7943 is endowed with a unique property, namely, the dual 
ability to control inflammation and rectify the autophagy response 
in CF.
RESULTS
The increase of VAPB and PTPIP51 expression  
impairs autophagy in CF bronchial cells during  
P. aeruginosa infection
To gain insight into the role of ER-mitochondria associations in CF 
during pathogen infection, we first monitored whether infection 
with P. aeruginosa affected the interaction of key ER-mitochondria 
Ca2+ exchange proteins, such as IP3R3 and VDAC, using a proximity 
ligation assay (PLA). Different human non-CF (S9 and NuLi) and 
CF (IB3-1 and CuFi) bronchial cell models, grown as monolayer on 
plastic supports, were exposed to P. aeruginosa laboratory strain 
(PAO1) or supernatant from mucopurulent material (SMM) from 
airways of patients with CF. No changes in IP3R3-VDAC interactions 
were quantified in non-CF bronchial cells challenged with P. aeruginosa 
or SMM (Fig. 1A and fig. S1A). In contrast, in CF bronchial cells, 
challenge with P. aeruginosa or SMM increased the interactions be-
tween IP3R3 and VDAC (Fig. 1A and fig. S1A). To test whether the 
increase in ER-mitochondria contacts was due to altered expression 
of ER-mitochondria tethers, we probed immunoblots of non-CF 
and CF bronchial cells exposed for different hours to P. aeruginosa. 
No change in the expression of IP3R3 and VDAC in both cell lines 
was detected (fig. S1B), whereas the expression of ER-mitochondria 
tethers, VAPB and PTPIP51, was increased in CF bronchial cells 
during pathogen exposure, suggesting that their increase could justify 
the augmented interaction of IP3R3 and VDAC (Fig. 1B and fig. S1, 
C and D). Similar effect on ER-mitochondria tethers has been 
observed also in polarized mucociliary-differentiated CF patient–
derived airway epithelial cells reconstituted on Transwell air-liquid 
interface (fig. S1E). CF primary airway cells showed enhanced 
VAPB and PTPIP51 expression compared to wild-type (WT) 
CFTR-expressing human primary cells when exposed to P. aeruginosa, 
which suggests that defective CFTR channel favors ER-mitochondria 
interaction during pathogen infection. A major ER-mitochondria 
interaction in CF bronchial cells when exposed to P. aeruginosa or 
SMM is also confirmed by the enhanced percentage of VAPB- 
PTPIP51 colocalization (fig. S2A).
By manipulating the expression of VAPB or PTPIP51, it is possible 
to modulate ER-mitochondria contacts affecting interorganelle Ca2+ 
exchange and autophagy (26). We quantified the level of autophagy 
present in non-CF and CF bronchial cells exposed to P. aeruginosa 
using the most common marker, microtubule-associated protein 1 
light chain 3 (LC3) protein. This protein is processed as LC3-I (~16 kDa) 
and the membrane-bound form LC3-II (~14 kDa), localized to 
preautophagosomes. By immunoblotting, the level of autophagy 
was quantified as ratio of LC3-II to LC3-I. P. aeruginosa led to sig-
nificantly down-regulated autophagic response in different CF cel-
lular models compared to non-CF cells under the same experimental 
conditions, as assessed by a decrease in the LC3-II/LC3-I ratio, which 
is indicative of defective autophagy (Fig. 1B and fig. S1, D and E). 
Negative regulation of autophagic machinery in CF cells was also 
confirmed by microscopy using the green fluorescent protein chimera 
LC3 (GFP-LC3) to monitor the formation of autophagosomes and 
by quantifying the number of cells that presented ring-shaped GFP-
LC3 structures after pathogen infection. Many cells with ring-shaped 
GFP-LC3 structures were observed in non-CF cells at different stages 
of infection (Fig. 1C). A marked reduction in the percentage of 
GFP-LC3–clustering cells was observed in CF cells, indicating minor 
processing and translocation of LC3-II from the cytosol to auto-
phagic vacuoles. These data were also confirmed by autophagic flux 
assay. The levels of LC3-II formation were monitored by immuno-
blotting in different non-CF and CF bronchial cellular models 
exposed to P. aeruginosa and then treated with saturating concen-
tration of bafilomycin A1. Bafilomycin A1 blocks the fusion of 
autophagosomes and lysosomes, and by inhibiting LC3-II, degra-
dation may modulate the kinetics of autophagosome synthesis. The 
ratio of LC3-II/LC3-I in the presence of bafilomycin A1 increased 
in non-CF cells exposed to P. aeruginosa, but this increase was 
restrained in CF cells, suggesting that the pathogen-induced auto-
phagic flux is reduced in CF cells (Fig. 1D and fig. S2, B and C). The 
reduction in the autophagic response observed in CF cells, during 
P. aeruginosa infection, could be due to the down-regulation of 
autophagy as a consequence of the enhanced VAPB-PTPIP51 tethers. 
To address this issue, we monitored autophagy by manipulating the 
expression of VAPB and PTPIP51 in non-CF bronchial cells. We 
transfected S9 cells with empty vector (mock), VAPB, and PTPIP51. 
This overexpression of VAPB or PTPIP51 markedly increased 
ER-mitochondria contacts enhancing the interactions between 
IP3R3 and VDAC in non-CF cells both under basal conditions and 
after P. aeruginosa exposure (Fig. 1E). Transfection of VAPB or 
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Fig. 1. The increase of ER-mitochondria tethering inhibits autophagy in CF bronchial cells during P. aeruginosa infection. (A) S9 (non-CF) and IB3-1 cells (CF) were 
infected with P. aeruginosa at an MOI of 100, and after 6 hours, proximity ligation assay (PLA) for IP3R3 and VDAC interactions was performed. Representative images with 
PLA signals (red) in the different cells are shown. The cell nuclei were stained with 4′,6-diamidino-2-phenylindole (blue). The bar chart shows quantification of PLA signals 
(%), respect to uninfected S9 cells (n = 25 to 30 independent visual field for each condition of three independent experiments). (B) (I) Immunoblots show VAPB and 
PTPIP51 expression in S9 (non-CF) and IB3-1 (CF) cells during P. aeruginosa infection. The cells were uninfected or infected for 3, 6, and 12 hours. The samples were probed 
using the antibodies indicated, where actin is used as loading control. Protein molecular mass markers are indicated in kilodalton. (II) Bar chart shows the ratio LC3-II/LC3-I 
following quantification of signals from immunoblots (n = 5). (C) S9 (non-CF) and IB3-1 cells (CF) were transfected with GFP-LC3–encoding plasmid then infected with 
P. aeruginosa, as indicated. Representative images of GFP-LC3–transfected non-CF and CF cells have been reported. The bars depict the percentage of cells showing the 
accumulation of GFP-LC3 in cluster (n = 10 to 20 independent visual field for each condition of three independent experiments). (D) Cells were infected with PAO1 at an 
MOI of 100 MOI for 6 hours and then treated with either vehicle or bafilomycin A1 (100 nM) as indicated. (I) Samples were probed on immunoblots for LC3 and -tubulin 
as a loading control. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification of signals from immunoblots (n = 10). (E) VAPB or PTPIP51 overexpression increases 
the IP3R3-VDAC interactions in S9 cells. The bar chart shows quantification of PLA signals (%) respect to uninfected non-CF mock cells (n = 45 independent visual 
field for each condition of three independent experiments). (F) (I) VAPB or PTPIP51 overexpression was probed using Myc-tag and HA-tag antibodies, respectively, while 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is used as a loading control. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification of signals from 
immunoblots (n = 4). (G) LC3-clustering cell count in mock and VAPB- or PTPIP51-overexpressing S9 cells during pathogen infection was performed. The bars depict the 
percentage of cells showing the accumulation of GFP-LC3 in cluster (n = 40 independent visual field for each condition of three independent experiments). (H) (I) VAPB or 
PTPIP51 overexpression inhibits autophagic flux in S9 cells during P. aeruginosa infection. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification of signals from 
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percentage of GFP-LC3–clustering cells (Fig. 1G) in non-CF cells 
exposed to pathogen at different time points. Moreover, whereas 
treatment with bafilomycin A1 increased the levels of LC3-II in mock 
non-CF cells, the magnitude of this increase was reduced in VAPB- 
and PTPIP51-transfected non-CF cells, confirming that the enhanced 
expression of VAPB or PTPIP51 tethers reduces autophagic response 
also in non-CF bronchial cells (Fig. 1H).
Effects of P. aeruginosa–induced VAPB and PTPIP51 
expression on selective autophagic responses
During pathogen infection, selective autophagic responses (mito-
phagy and xenophagy) contribute together to protect and maintain 
cellular homeostasis. To test whether their roles could be compro-
mised in CF, we first checked whether P. aeruginosa induced a 
mitophagic response in non-CF and CF bronchial cells. The cells 
were plated and infected with P. aeruginosa, and after intracellular 
protein fractionation, the expression level and localization of early 
[optineurin and nuclear dot protein 52 kDa (NDP52)] and late (LC3) 
mitophagic markers were immunoblotted (Fig. 2A). Optineurin and 
NDP52 are cytosolic receptors that are also involved in the xenophagic 
response and are recruited by PINK1 (phosphatase and tensin 
homolog-induced kinase 1) in the first steps of mitophagy (27). They 
are responsible for recognizing damaged mitochondria migrating 
to organelles and for promoting their sequestration into autophago-
somes. In both cell lines, mitophagic receptors accumulated in the 
mitochondrial fraction after P. aeruginosa infection, triggering the 
mitophagic response (Fig. 2A and fig. S3A). The reduced mitochondrial 
redistribution of LC3-II in CF cells suggested slower kinetics of 
autophagosome synthesis and thus of mitochondrial sequestration 
compared with non-CF cells (fig. S3A, III). These data were confirmed 
by colocalization analysis between GFP-LC3 and mitochondrial- 
targeted red fluorescent protein (mtRFP) (Fig. 2B). As shown by the 
graph, the number of mitochondria that colocalized with GFP-LC3 
clustering was lower in CF cells than in non-CF cells at different 
stages of pathogen infection. To potentiate the mitophagic response, 
the kinase PINK1 (phosphatase and tensin homolog–induced 
kinase 1) phosphorylates Parkin, an E3 ubiquitin ligase that trans-
locates to the altered mitochondria to increase the rate of auto-
phagosome synthesis (27).
Using confocal microscopy, we evaluated the levels of Parkin 
recruited to mitochondria through colocalization analysis between 
mitochondrial-targeted GFP (mtGFP) and chimeric Parkin cherry. 
The P. aeruginosa–dependent clustering of Parkin to mitochondria 
in both cell lines was quantified and expressed as the percentage of 
positive Parkin-clustering cells and as number of mitochondria co-
localizing with Parkin clusters for cell (Fig. 2C). In CF bronchial cells, 
a small percentage of Parkin-clustering cells with respect to non-CF 
cells was quantified during pathogen infection (Fig. 2, C to I). This 
reduced amplification of mitophagic response in CF cells was also 
confirmed by fewer mitochondria colocalization with Parkin cluster 
(Fig. 2C, II). These results highlight a defect in mitochondrial se-
questration during the P. aeruginosa–triggered mitophagic response 
in CF cells, characterized by reduction of the Parkin-mediated am-
plifying signal.
Although P. aeruginosa is primarily considered an extracellular 
pathogen, reports have demonstrated that, throughout the course 
of infection, the bacterium acquires the ability to enter and reside 
within host cells (28). CFTR channel defects could also lead to a 
reduction in xenophagy during pathogen infection, considering 
that xenophagy and mitophagy are two different events linked by 
common factors. We measured the xenophagic clearance activity 
and the P. aeruginosa invasion capacity in CF and non-CF bronchial 
cells. As expected, reduced xenophagic clearance of invading pathogen 
was detected in CF compared to non-CF cells (Fig. 2D, I). Similar 
effect on xenophagy has also been confirmed in other CF bronchial 
cell model and in polarized CF patient–derived airway cells (fig. S3B). 
In both cases, the higher number of colony-forming unit (CFU) per 
milliliter of invading bacteria in CF bronchial cells with respect to 
non-CF indicates a reduction of xenophagic clearance capacity. 
Through a bacterial invasion assay, we excluded that the accumula-
tion of intracellular bacteria in CF bronchial cells depended on 
potentiated bacterial invasion (Fig. 2D, II). Last, colocalization 
analysis was performed between NDP52 and invading pathogens 
(Fig. 2E). Representative images show the intracellular redistribution 
of NDP52 around invading bacteria to facilitate sequestration. 
A reduced percentage of colocalization between NDP52 and invading 
bacteria was detected in CF bronchial cells with respect to non-CF 
cells, confirming a minor xenophagic clearance capacity of CF 
bronchial cells.
These data are in line with the previously described results of 
mitophagy, confirming that, in CF bronchial cells, defects of CFTR 
channel led to down-regulation of xenophagic and mitophagic re-
sponses with subsequent accumulation of invading bacteria (Fig. 2D 
and fig. S3B) and dysfunctional mitochondria, characterized by re-
duced mitochondrial membrane potential (m) (fig. S3C) and 
increased mitochondrial reactive oxygen species (ROS) (fig. S3D).
The defective mitophagy in CF cells could be a crucial mecha-
nism of the P. aeruginosa–dependent inflammatory exacerbation 
because its failure to remove P. aeruginosa–damaged mitochondria 
during infection leads to mitochondrial ROS production and in-
flammasome activation, with profound effects on cell physiology 
and cell viability. Similar effects are ascribable to defective xenophagy 
because impaired degradation of invading bacteria could result in 
cell stress and pyroptosis induction.
Reduced selective autophagic responses potentiate UPRmt 
and inflammasome activation, favoring a vicious cycle
Cells sense and respond to mitochondrial dysfunction by activating 
a protective transcriptional program known as UPRmt, which in-
cludes genes that promote mitochondrial protein homeostasis and 
the recovery of defective organelles. A genetic screen in Caenorhabditis 
elegans identified the transcription factor ATFS-1 (activating tran-
scription factor associated with stress-1) as a key regulator of UPRmt. 
During mitochondrial dysfunction, ATFS-1 traffics from the cyto-
sol to the nucleus, where it induces transcription of mitochondrial 
chaperones [HSP10 and HSP60 (heat shock 10 kDa protein and 
heat shock 60 kDa protein)], proteases [CLPP (Caseinolytic Mito-
chondrial Matrix Peptidase Proteolytic Subunit)], and antibacterial 
innate immune genes (8). A similar transcriptional response has 
been described in mammals in which the putative roles of lc ATF4 
(activating transcription factor 4) and ATF5, which have consider-
able homology to ATFS-1, are indicated (29). During mitochondrial 
dysfunction, ATF5 fails to be imported into mitochondria and traffics 
to the nucleus, inducing gene transcription.
The P. aeruginosa–dependent triggering of UPRmt was evaluated 
by ATF5 and ATF4 nuclear translocation in different CF and non-
CF bronchial cellular models. Representative images show the 
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Fig. 2. During P. aeruginosa infection the mitophagic and xenophagic response in CF bronchial cells is impaired. (A) Uninfected and P. aeruginosa–infected airways 
cells homogenates (hom) of IB3-1 (CF) and S9 (non-CF) cells were fractionated to obtain pure mitochondria (mit) and cytosol (cyt) fractions. Equal amount of proteins 
(10 g) from each fraction were analyzed by Western blot using the indicated antibodies. VDAC and actin are, respectively, mitochondrial and cytosolic markers. (B) (I) 
Representative images of S9 and IB3-1 cells cotransfected with GFP-LC3 and mitochondrial RFP and then treated with PAO1 at an MOI of 100 for 6 hours. (II) Quantitative 
analysis of S9 and IB3-1 cells that contain mitochondria-localized LC3 puncta; the values are expressed as mean number of colocalized-puncta counts per cell (n = 15 to 
20 independent visual field for each condition of three independent experiments). (C) (I) Representative images of mitochondrial redistribution of Parkin in S9 and IB3-1 
cells after P. aeruginosa infection. Cells were cotransfected with Parkin cherry and mitochondrial GFP and then treated with PAO1 at an MOI of 100 for 6 hours. (II) The bars 
depict the percentage of cells showing the accumulation of Parkin in cluster. (III) Quantitative analysis of cells that contain mitochondria-localized Parkin cluster, the 
values are expressed as mean number of colocalized-cluster counts per cell (n = 20 to 22 independent visual field for each condition of at least three independent experi-
ments). (D) (I) Infected S9 and IB3-1 cells were lysed after the addition of impermeable antibiotics and streaked on LB agar plates for the determination of intracellular 
colony-forming units (CFUs) (n = 8 of independent experiments). (II) Double bacteria labeling and confocal microscopy to quantify bacterial invasion in whole S9 and 
IB3-1 cells exposed for 6 hours to GFP–P. aeruginosa. The bars show the ratio GFP/RFP signal in non-CF and CF bronchial cells, as described in experimental procedure 
section. (E) (I) Representative images of intracellular P. aeruginosa internalization and recruitment of NDP52 to pathogen in IB3-1 cells. (II) The bar chart shows quantifica-
tion of colocalization signals (%) between NDP52 and pathogen in S9 and IB3-1 cells (n = 8 to 13 independent visual field for each condition of at least three independent 
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Fig. 3. Abnormal P. aeruginosa–dependent UPRmt activation lead to worsening of autophagic defect and of inflammatory response in CF bronchial cells. 
(A) Representative confocal images of nuclear translocation of endogenous ATF5 (I) and ATF4 (II) in S9 (non-CF) and IB3-1 (CF) cells during pathogen infection. The graphs 
report the nuclear redistribution of ATF5 and ATF4 after PAO1 infection, expressed as percentage increase in fluorescent ratio signals (from cytosol to nucleus) with re-
spect to uninfected condition (n = 6 to 10 independent visual field for each condition of three independent experiments). (B) Immunoblots of IB3-1 and S9 cells uninfected 
or infected for 3, 6, and 12 hours, as indicated. The samples were probed using the antibodies indicated, where actin is used as loading control. (C) (I) Autophagic flux in 
IB3-1 cells overexpressing ATF5 during P. aeruginosa infection. GFP- and ATF5GFP-transfected cells were infected with PAO1 at 100 MOI for 6 hours and then treated with 
bafilomycin A1, as indicated. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification of signals from immunoblots (n = 6). (D) Immunoblots of cleaved caspase-1 
and processed IL-1 from lysates (lys) or supernatants (sur) of IB3-1 and ATF5-overexpressed IB3-1 cells infected for 6 hours with P. aeruginosa. Actin was used as loading 
control. The quantification is expressed as the ratio of casp-1–p10/actin and cleaved IL-1/actin. The bars are the means ± SE of four independent immunoblots. (E) IB3-1 and 
S9 cells were transfected with ATF5-GFP and after 6 hours of PAO1 infection, and the cultured cell supernatant were collected to quantify the levels of proinflammatory 
cytokines by enzyme-linked immunosorbent assay (ELISA) (n = 5 of independent experiments). The selective inhibitor of caspase-1, 20 M Ac-YVAD-cmk, was added 
30 min before infection. (F) Murine WT and NLRP3-null (NLRP3 KO)–derived embryonic fibroblasts (MEFs) were infected with PAO1 at an MOI of 100 for 6 hours and then 
treated with either vehicle or bafilomycin A1 as indicated. (I) Samples were probed on immunoblots for LC3 and actin as a loading control. (II) Bar chart shows the ratio 
LC3-II/LC3-I following quantification of signals from immunoblots (n = 4). The reported data are means ± SE of at least three independent experiments. (G) Infected WT 
and NLRP3 KO MEFs were lysed after the addition of impermeable antibiotics and streaked on LB agar plates for the determination of intracellular CFUs (n = 3 of indepen-
dent experiments). (H) WT and NLRP3 KO MEFs were transfected with ATF5-GFP and after 6 hours of PAO1 infection, and the cultured cell supernatant were collected to 
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P. aeruginosa infection (Fig. 3A and fig. S4A). Major ATF5 and ATF4 
nuclear redistribution was measured in CF cells with respect to non-CF 
cells challenged with P. aeruginosa, suggesting that UPRmt is mainly 
induced in CF cells (Fig. 3A and fig. S4A). P. aeruginosa–dependent 
UPRmt activation was also monitored by immunoblotting and quanti-
fication of UPRmt reporters, such as HSP10, HSP60, and CLPP 
(Fig. 3B and fig. S4, B and C). Increased expression levels of UPRmt 
reporters followed the abnormal UPRmt induction promoted by the 
stabilization of ATF5 and ATF4 in CF cells during pathogen infec-
tion. Similar results were also obtained in polarized CF patient–
derived airway cells, where the stabilization and dimerization of 
ATF5, induced by P. aeruginosa infection, corresponded to an in-
crement of UPRmt reporters (fig. S4D).
Considering the defective mitophagy and consequent accumula-
tion of dysfunctional mitochondria, persistent activation of UPRmt 
was assessed in CF cells when exposed to pathogen infection. Since 
ATF5 has been shown to suppress autophagy in human BCR-ABL–
transformed cells (30), we questioned whether the stabilization of 
ATF5 in CF cells, and thus the persistent UPRmt activation, affected 
P. aeruginosa–triggered autophagy and inflammation. To mimic UPRmt 
hyperactivation, we transfected the chimera ATF5-GFP into CF bronchial 
cells. This overexpression favored the stabilization of ATF4 and markedly 
increased the susceptibility to P. aeruginosa–triggered UPRmt acti-
vation, enhancing the expression level of UPRmt reporters in CF cells, 
both under basal conditions and upon P. aeruginosa infection (Fig. 3C 
and fig. S5A). Moreover, transfection of different CF bronchial cel-
lular models with ATF5, then exposed to P. aeruginosa, decreased 
the LC3-II/LC3-I ratio according to the autophagic flux assay, indi-
cating that persistent UPRmt activation in CF cells during pathogen 
infection further decreases the rate of autophagic response (Fig. 3C 
and fig. S5B). ATF5 overexpression resulted in enhanced inflam-
matory sensitivity to pathogen infection in CF bronchial cells, as shown 
by increased expression level of cleaved caspase-1 and cleaved cytokine 
interleukin–1 (IL-1) in cell supernatant (Fig. 3D and fig. S5C) and 
by higher level of inflammasome-dependent IL-1 and IL-18 release 
(Fig. 3E and fig. S5D). The forced expression of ATF5 strengthened 
the inflammasome- dependent IL-1 release after incubation with 
P. aeruginosa in non-CF bronchial cells (Fig. 3, E to I, and fig. S5, D 
to I), the same cells, where the presence of wt CFTR mitigates the 
P. aeruginosa–dependent mitochondrial effects, avoiding NLRP3 
inflammasome activation (7).
However, the exacerbation of the P. aeruginosa–triggered in-
flammation promoted by ATF5 overexpression was attenuated by 
the pretreatment with caspase-1 inhibitor Ac-YVAD-cmk (20 M), 
which, by affecting the inflammasome, reduced the release of cyto-
kines (Fig. 3E and fig. S5D) and ameliorated the rate of autophagic 
response in CF bronchial cells (fig. S5E). These results confirm that 
the synergy between P. aeruginosa–dependent mitochondrial stress 
and consequent abnormal UPRmt activation leads to worsening of 
autophagic defects and inflammatory responses in CF cells.
Additional data obtained in NLRP3 knockout (KO) and WT 
mouse embryonic fibroblasts (MEFs) suggested that the down- 
regulation of autophagy during P. aeruginosa infection is also strictly 
related to NLRP3 inflammasome activation (Fig. 3F). By autophagic 
flux assay, the LC3-II conversion in the presence of bafilomycin A1 
increased in WT fibroblasts, but this increase was augmented in 
NLRP3 KO fibroblasts, both under basal condition and after 
P. aeruginosa infection, indicating that loss of NLRP3 stimulates 
autophagic flux. NLRP3 deficiency augmented bacterial clearance 
capacity in NLRP3 KO MEFs with respect to WT MEFs (Fig. 3G), 
while the NLRP3 activator nigericin (10 M) treatment reduced the 
bacterial clearance capacity in CF bronchial cells, enhancing further 
the number of CFU per milliliter of invading pathogen (fig. S5F). 
Last, the deletion of NLRP3 in MEFs prevented the inflammasome- 
dependent IL-1 and IL-18 release in ATF5-overexpressing NLRP3 KO 
MEFs during P. aeruginosa infection (Fig. 3H). Collectively, these 
findings show that the worsening of defective autophagy in CF 
bronchial cells, started by P. aeruginosa–induced VAPB and PTPIP51 
expression, is also sustained by abnormal UPRmt and NLRP3 
inflammasome activation, contributing to persistent accumulation 
of damaged mitochondria and invading bacteria.
Regulation of ER-mitochondria tethering controls Ca2+ 
exchange and abrogates the effects of tethering 
on autophagy
The expression of VABP or PTPIP51 both led to an increase in 
IP3R3-VDAC interactions (fig. S6A). We monitored whether over-
expression of VAPB or PTPIP51 affected the uptake of Ca2+ by 
mitochondria following IP3R-mediated release from the ER store. 
For these experiments, we cotransfected, in different CF bronchial 
cellular models, empty vector (pcDNA3), VAPB, or PTPIP51 and 
mitochondrial-targeted aequorin Ca2+ probe. We triggered physio-
logical IP3R-mediated Ca2+ release by stimulation with 100 M 
histamine. As expected, transfection of both VAPB and PTPIP51 
induced a significant increase in mitochondrial Ca2+ response 
(Fig. 4A and fig. S6B) and had no effects on cytosolic Ca2+ levels 
(fig. S6C). We therefore investigated whether the reduction in auto-
phagy induced by VAPB or PTPIP51 overexpression is caused by a 
higher Ca2+ transfer to mitochondrial matrix. To verify this hypothesis, 
we first quantified the changes in IP3R3-VDAC interactions by PLA 
in MCU-silenced CF bronchial cells (shMCU-CF cells) transfected 
with pcDNA3, VAPB, or PTPIP51 during pathogen infection or 
SMM treatment (Fig. 4B and fig. S6D). The silencing of MCU 
induced a reduction in the protein expression (fig. S6E) and in 
histamine-dependent mitochondrial Ca2+ uptake (fig. S6F) without 
affecting the m (fig. S6G). The reduction in mitochondrial Ca2+ uptake 
in shMCU-CF cells protected the mitochondria from P. aeruginosa–
dependent m loss, decreasing mitochondrial superoxide production and 
NLRP3 activation (7). The maintenance of mitochondrial physiology 
in shMCU-CF cells during P. aeruginosa infection is also confirmed by 
lacked P. aeruginosa–triggering nuclear translocation of transcription 
factors ATF5 and ATF4, avoiding the UPRmt activation (fig. S6H).
Under basal conditions, the overexpression of VAPB or PTPIP51 
increased the association between the two ER-mitochondria Ca2+ 
exchange proteins, IP3R3-VDAC in shMCU-CF cells. In contrast, 
no significant differences emerged between empty vector–transfected 
shMCU-CF cells (pcDNA3) and nonsilenced CF cells (Mock). In 
CF cells, P. aeruginosa exposure led to a marked enhancement of 
IP3R3-VDAC PLA signaling (Figs. 1A and 4B). This increase was 
abrogated both in pcDNA3-transfected shMCU-CF cells and in VAPB- 
or PTPIP51-overexpressing shMCU-CF cells, indicating that the 
changes in IP3R3-VDAC interactions during pathogen infection are 
strictly dependent on MCU (Fig. 4B). The gain of IP3R3-VDAC in-
teraction in CF bronchial cells exposed to P. aeruginosa or SMM 
could be the consequence of compensatory responses that promote 
the increase of VAPB and PTPIP51 expression, at front of pathogen- 
dependent mitochondrial perturbations, which impairs m and thus 
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Fig. 4. MCU targeting abrogates the effects of VAPB and PTPIP51 on autophagy, restoring the mitochondrial physiology in CF bronchial cells exposed to pathogen. 
(A) Mitochondrial Ca2+ response in IB3-1 cells (CF cells) overexpressing VAPB or PTPIP51; representative traces are shown. Cells were cotransfected with mitochondrial- 
targeted aequorin with control empty vector (pcDNA3), VAPB, or PTPIP51 and stimulated with 100 M histamine. (B) Stable MCU-silenced IB3-1 clone (IB3-1 shMCU) was 
transfected with pcDNA3, VAPB, or PTPIP51 and then infected with PAO1 at an MOI of 100 for 6 hours. PLA for IP3R3 and VDAC interactions was performed. The bar chart 
shows quantification of PLA signals (%), with respect to uninfected IB3-1 cells (mock) (n = 15 independent visual field for each condition of three independent experiments). 
(C) LC3-clusteing cell count in pcDNA3 and VAPB- or PTPIP51-overexpressing IB3-1 shMCU cells during pathogen infection was performed. The bars depict the percentage 
of cells showing the accumulation of GFP-LC3 in cluster (n = 25 independent visual field for each condition of at least three independent experiments). (D) Effects of VAPB 
and PTPIP51 on autophagic flux in IB3-1 shMCU cells during pathogen infection. (I) Samples were probed on immunoblots for LC3 and GAPDH as a loading control. (II) Bar 
chart shows the ratio LC3-II/LC3-I following quantification of signals from immunoblots (n = 6). (E) The effects of MCU-inhibition by 1 M KB-R7943 pretreatment on super-
oxide production in CF bronchial cells during PAO1 infection. The quantification of percentage change of cells positive for MitoSox staining compared with uninfected IB3-1 
cells is shown (n = 8 independent experiments). (F) Levels of IL-1 and IL-18 in KB-R7943–treated mock and ATF5-overexpressing IB3-1 cells, collected after 6 hours of PAO1 
infection at an MOI of 100 (n = 10 independent experiments). (G) Measurements of mitochondrial  in KB-R7943–treated and untreated IB3-1 cells during bacterial infec-
tion. The bars show the change in the TMRM fluorescence level before and after treatment with P. aeruginosa strain, expressed as the percentage change with respect to 
untreated IB3-1 cells. FCCP was used to collapse the mitochondrial  (n = 12 independent experiments). F.A.U., fluorescent arbitrary units. (H) Histamine-dependent mito-
chondrial Ca2+ responses of KB-R7943 pretreating IB3-1 cells at different time points before and after PAO1 infection. The histograms show all means ± SE of mitochondrial Ca2+ 
responses (n = 5 independent experiments). (I) S9 (non-CF) and IB3-1 cells (CF) were pretreated with KB-R7943 1 hour before the infection with PAO1 at an MOI of 100. PLA for 
IP3R3 and VDAC interactions was performed. The bar chart shows quantification of PLA signals (%), with respect to uninfected S9 cells (n = 15 independent visual field for each 
condition). The reported data are as means ± SE of at least three independent experiments. (J) Mitochondrial Ca2+ dynamics in S9- (non-CF), IB3-1– (CF), and KB-R7943–treated 
IB3-1 (CF-KB-R7943) cells exposed to PAO1 at an MOI of 100 were evaluated through ratiometric imaging of mitochondrial-targeted GCaMP6. Traces represent means ± SE of 
mitochondrial Ca2+ response from at least of 10 independent experiments. SE values are illustrated using gray shading. For statistical significance, the multiple Student’s t test 
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We also monitored how MCU silencing affected autophagy in 
VAPB- or PTPIP51-overexpressing CF cells. MCU silencing in CF 
cells, challenged with P. aeruginosa, induced a significant increase 
in the percentage of GFP-LC3–clustering cells with respect to naive 
CF cells (Fig. 4C). However, the inhibitory effects of VAPB and 
PTPIP51 overexpression on the percentage of GFP-LC3–clustering 
cells were abrogated in shMCU-CF cells exposed to P. aeruginosa 
(Fig. 4C). Moreover, treatment with bafilomycin A1 not only con-
firmed that the silencing of MCU increased the LC3-II/LC3-I ratio, 
demonstrating an induction of autophagy, but also showed that this 
increase was unaffected by overexpression of VAPB or PTPIP51 
(Fig. 4D). Thus, the inhibitory effect of VAPB and PTPIP51 on 
autophagy in CF bronchial cells is lost by blocking mitochondrial 
Ca2+ uptake. In this case, it is also possible to prevent the in-
crease in IP3R3-VDAC interactions during pathogen infection due 
to P. aeruginosa–induced VAPB and PTPIP51 expression (Fig. 4B).
MCU inhibition limits the P. aeruginosa–dependent 
inflammatory response and mitochondrial stress,  
promoting autophagy
All these results identify MCU as a candidate target to limit P. aeruginosa–
mediated hyperinflammation in the CF lung, raising the question of 
its druggability in the CF inflammatory model. In this view, we tested 
the MCU inhibitor KB-R7943 (1 M), pretreating CF bronchial 
cells 1 hour before challenging with P. aeruginosa. The selected con-
centration of drug is useful to partially reduce mitochondrial Ca2+ 
uptake in CF bronchial cells. KB-R7943, which was developed to 
inhibit the reverse mode of Na+/Ca2+ exchange (NCX) in intact cells, a 
lower concentration has been shown to be a potent MCU inhibitor, 
an effect that contributes to its protective activity (31). In addition, 
given that CF cells (IB3-1) used in our in vitro experiments lack any 
plasma membrane (PM) NCX activity (32), KB-R7943 could be 
considered a specific MCU inhibitor in these CF cells. KB-R7943 
pretreatment prevented P. aeruginosa–triggered mitochondrial dys-
function in CF bronchial cells, reducing mitochondrial ROS pro-
duction (Fig. 4E), inflammasome activation (fig. S7A), and the 
inflammasome-dependent IL-1 and IL-18 release (Fig. 4F and fig. S7B). 
The anti-inflammatory effect of KB-R7943 was also confirmed by 
reduced levels of IL-1 and IL-18 released in the culture super-
natants of ATF5-overexpressing CF cells after exposition to bacteria, 
abrogating the amplification of P. aeruginosa–triggered inflammasome 
response induced by abnormal UPRmt activation (Fig. 4F and fig. S7B).
Reports have purported that the protective effect of KB-R7943 is 
due in part to mild m depolarization and/or complex I inhibition 
(33, 34). Successively, these considerations have been questioned, 
demonstrating that KB-R7943 has no negative impact on mito-
chondrial respiration and m (35). However, KB-R7943 pretreatment 
did not alter m in CF bronchial cells under basal condition, 
excluding an effect on the mitochondrial respiratory capacity and 
m (Fig. 4G); KB-R7943 prevented m loss observed in CF 
bronchial cells upon prolonged pathogen infection (Fig. 4G). The 
effect of MCU inhibition on intracellular Ca2+ signaling was evalu-
ated using aequorin-based measurement. KB-R7943 alone induced 
a reduction in histamine-dependent mitochondrial Ca2+ response 
in CF cells (Fig. 4H and fig. S7C) without affecting cytosolic tran-
sient and ER Ca2+ content (fig. S7D), indicating once more that the 
effect of KB-R7943 on mitochondrial Ca2+ signaling is not ascribable to 
perturbed mitochondrial respiratory capacity but only to the selec-
tive inhibition of MCU. No differences in histamine-dependent mito-
chondrial (Fig. 4H) and cytosolic (fig. S7E) Ca2+ responses were 
emerged between P. aeruginosa–infected KB-R7943–treated CF 
cells and uninfected KB-R7943–treated CF cells. The lacked synergistic 
reduction of mitochondrial Ca2+ response in P. aeruginosa–infected 
KB-R7943–treated CF cells (in theory, due to KB-R7943–dependent 
MCU inhibition and to P. aeruginosa–induced m dissipation) 
demonstrates that KB-R7943 through the inhibition of MCU pre-
serves the m during pathogen infection, preventing mitochondrial 
damage that could further affect the mitochondrial Ca2+ uptake 
capacity of CF bronchial cells (Fig. 4H).
We also demonstrated that, when preventing P. aeruginosa–
dependent mitochondrial dysfunction by KB-R7943, the increases 
in IP3R3-VDAC interactions during bacterial infection or SMM 
were lost (Fig. 4I). We suppose that the exacerbation of the P. aeruginosa–
triggered inflammatory response is mitigated by MCU inhibition, 
which avoids a mitochondrial Ca2+ overload due to compensatory 
increased ER-mitochondria interaction, which, in turn, favors a higher 
ER-mitochondria Ca2+ transfer in CF bronchial cells during pathogen 
infection. To demonstrate this, we performed mitochondrial Ca2+ 
measurement using the ultrasensitive mitochondrial GFP-based Ca2+ 
probe, mtGCaMP6, useful to measure fast and small mitochondrial 
Ca2+ change (Fig. 4J and fig. S7F). Acute exposure of CF bronchial 
cells to P. aeruginosa or SMM induced a sustained increase of mito-
chondrial Ca2+ concentration (Fig. 4J and fig. S7F). Conversely, by 
inhibiting MCU with KB-R7943, the mitochondrial Ca2+ uptake in 
CF bronchial cells exposed to pathogen or SMM was abrogated. No 
perturbation in mitochondrial Ca2+ signaling was detected in non-
CF bronchial cells when exposed to P. aeruginosa or SMM (Fig. 4J 
and fig. S7F), confirming a higher ER-mitochondria Ca2+ transfer 
in CF bronchial cells. The concept of mitochondrial Ca2+ overload, 
however, does not necessarily refer solely to a very large increase in 
mitochondrial Ca2+ concentration, rather much smaller, but pro-
longed, increases of Ca2+ may activate the organelle dysfunctional 
machinery, leading to m dissipation, reduced ATP production, 
increased release of ROS, protein tyrosine phosphatase opening, 
and mitochondria swelling (20).
Then, we monitored whether KB-R7943 affected autophagy in 
CF bronchial cells when exposed to P. aeruginosa. The higher LC3-
II/LC3-I ratio (Fig. 5A and fig. S8A) and percentage of GFP-LC3–
clustering cells (Fig. 5B) in KB-R7943–treated CF cells than in 
untreated CF cells indicated recovery of autophagy during infection. 
Treatment with bafilomycin A1 confirmed that KB-R7943 pretreatment, 
by preventing mitochondrial Ca2+ overload, increased the LC3-II/
LC3-I ratio in CF cells upon P. aeruginosa challenge and thus auto-
phagy (Fig. 5C). However, the increase in LC3-II/LC3-I ratio (Fig. 5D) 
and percentage of GFP-LC3–clustering cells (Fig. 5E) in KB-R7943–
treated CF cells exposed to the pathogen were unaffected by over-
expression of tethers, VAPB or PTPIP51. The recovery of autophagy 
in KB-R7943–treated CF cells, by MCU inhibition, potentiated the 
bacterial clearance activity in different CF bronchial cell models when 
exposed to bacteria (Fig. 5F and fig. S8B), ameliorating cell viability 
(Fig. 5G and fig. S8C). To exclude the possibility that KB-R7943 has 
toxic effects on bacterial viability and proliferation, we evaluated 
P. aeruginosa growth under different concentrations of KB-R7943. 
No changes in the bacterial growth curve emerged (fig. S8D). In line 
with the data of MCU silencing, the inhibition of mitochondrial 
Ca2+ uptake abrogates the inhibitory effects of VAPB and PTPIP51 
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KB-R7943 mitigates the P. aeruginosa–triggered 
inflammatory response in vivo
Last, we analyzed the efficacy of KB-R7943 in counteracting pathogenic 
CF lung inflammation in vivo. C57Bl/6 Cftrtm1UNCTgN(FABPCFTR)#Jaw 
(CFTR-KO) mice and their WT (non-CF) littermates were infected 
with P. aeruginosa AA43 clinical isolate embedded in agar beads and 
treated with KB-R7943 (300 g/kg) or vehicle (ctrl) via aerosol ad-
ministration by the Penn-Century MicroSprayer Aerosolizer. The 
schedule of treatment was 1 hour before infection and then every 12 hours. 
Two days after infection and 1 hour after the last treatment, murine 
lungs and bronchialalveolar lavage fluid (BALF) were collected and 
processed. First, we evaluated the KB-R7943 distribution in tissues 
of treated mice by mass spectrometry. The drug was detected both 
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Fig. 5. KB-R7943 restores the autophagic response in CF bronchial cells. (A) (I) Immunoblot of untreated and KB-R7943–treated IB3-1 cells infected with PAO1 at an 
MOI of 100 for 6 hours. The samples were probed for LC3 and actin as a loading control. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification of signals from 
immunoblots (n = 5). (B) LC3-clustering cell count in untreated and KB-R7943–treating IB3-1 cells was performed. The bars depict the percentage of cells showing the 
accumulation of GFP-LC3 in cluster during P. aeruginosa infection (n = 20 independent visual field for each condition of at least three independent experiments). (C) Ef-
fects of KB-R7943 on autophagic flux in IB3-1 cells during pathogen infection. (I) Samples were probed on immunoblot for LC3 and GAPDH as a loading control. (II) Bar 
chart shows the ratio LC3-II/LC3-I following quantification of signals from immunoblots (n = 6). (D) Immunoblots of mock and VAPB- and PTPIP51-overexpressing IB3-1 
cells pretreated with KB-R7943 1 hour before P. aeruginosa infection, as indicated. (I) Samples were probed on immunoblot for LC3 and actin as a loading control. (II) Bar 
chart shows the ratio LC3-II/LC3-I following quantification of signals from immunoblots (n = 6). (E) LC3-clustering cell count was performed in mock and VAPB- or 
PTPIP51-overexpressing IB3-1 cells exposed to MCU-inhibitor, KB-R7943, and PAO1 at an MOI of 100, as indicated. The bars show the percentage of cells showing the 
accumulation of GFP-LC3 in cluster (n = 20 independent visual field for each condition of at least three independent experiments). (F) S9, KB-R7943–treating IB3-1 cells, 
and/or IB3-1 shMCU cells were infected with PAO1 at an MOI of 100 for 6 hours and then lysed after the addition of impermeable antibiotics and streaked on LB agar plates 
for the determination of intracellular CFUs (n = 10 of independent experiments). (G) Effect of KB-R7943 on IB3-1 cell apoptosis, during P. aeruginosa infection, using annexin 
V Alexa Fluor 488/propidium iodide staining. Cells were plated in 60-mm plates and treated for 1 hour with KB-R7943 before PAO1 infection, as indicated. Cell viability 
and death were evaluated using a Tali apoptosis kit and the Tali image-based cytometer. Bars show the percentage of IB3-1 (CF) and S9 (non-CF) cells that were annexin 
V–fluorescein isothiocyanate–positive (n = 6 independent experiments). The reported data are means ± SE of at least three independent experiments. Student’s t test was 
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Fig. 6. KB-R7943 limits the P. aeruginosa–triggered inflammatory response in CF mice. C57BL/6 Cftrtm1UNCTgN(FABPCFTR)#Jaw mice (CFTR-KO) (n = 20 for each ex-
perimental condition) and their WT littermates (n = 20 for each experimental condition) were inoculated with 1.5 × 106 CFU of P. aeruginosa AA43 isolate embedded in 
agar beads. Mice were treated with KB-R7943 (300 g/kg) or vehicle via aerosol administration by the Penn-Century MicroSprayer Aerosolizer every 12 hours starting 
1 hour before infection. Every 12 hours, mice were monitored for the health status. Two days after infection, 1 hour after the last treatment, murine lungs and BALFs were 
collected and processed. (A) Kaplan-Meier survival curve for untreated and KB-R7943–treated CFTR-KO mice. The data were analyzed by log-rank (Mantel-Cox) test and 
Gehan-Breslow-Wilcoxon test (P = 0.0378; GraphPad Prism, USA) (n = 20 mice for each condition of three independent experiments). (B) Clearance and infection were 
determined on surviving mice. The data were analyzed by Fisher’s test (confidence intervals, 95%; *P < 0.05; GraphPad Prism, USA) (n = 20 mice for each condition of three 
independent experiments). (C) Bacterial burden in the lungs of KB-R7943–treated and untreated mice after 2 days from P. aeruginosa challenge is shown. Bar chart repre-
sent means ± SE of lung CFU in mice. Data were analyzed by two-way ANOVA and Tukey’s post hoc test (*P < 0.05, n = 15 mice analyzed of three independent experi-
ments). (D) The images exemplify the lungs of WT and CFTR-KO mice stained with hematoxylin and eosin (H&E), pretreated 1 hour before infection with KB-R7943 and 
vehicle. Scale bars, 250 m (I, IV, VII, and X) and 500 m (II, III, V, VI, VIII, IX, XI, and XII). (E) Graphs summarize histological scoring of global inflammation grading based on 
H&E staining (n = 15 of independent experiments). Data were analyzed by Student’s t test used for indicated comparisons and by two-way ANOVA and Tukey’s post hoc test 
(**P < 0.01). (F) (I) Immunoblots show NLRP3 and LC3 expression in murine WT and CFTR-KO lung homogenates after P. aeruginosa infection. The samples were probed 
on immunoblots for NLRP3, LC3, and actin as a loading control. Bar chart shows the ratio NLRP3/actin (II) and ratio LC3-II/LC3-I (III) following quantification of signals from 
immunoblots (n =9 to 12). Student’s t test was used for indicated comparisons (*P < 0.05 and **P < 0.01). (G) The levels of released IL-1 (I) and IL-18 (II) were measured in 
BALF of WT and CFTR-KO mice exposed to P. aeruginosa infection, treated with KB-R7943 (300 g/kg) and vehicle. The data were analyzed by two-way ANOVA and Tukey’s 
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703.3 ± 150.3 pg/ml (CFTR-KO)] and in plasma [194.3 ± 87.3 pg/ml 
(WT) versus 173.9 ± 56.8 pg/ml (CFTR-KO)], confirming that it is 
a permeable and stable drug (fig. S9A).
To define the therapeutic effect of KB-R7943 in CFTR-KO and 
WT mice, we measured the survival, bacterial burden, and inflam-
matory response. Survival of CFTR-KO mice after P. aeruginosa 
infection was significantly improved by KB-R7943 treatment [80% 
(vehicle) versus 100% (KB-R7943)] (Fig. 6A). In addition, KB-R7943 
treatment of CFTR-KO mice led to significantly increased clearance 
of P. aeruginosa infection both in the lung and BALF (Fig. 6B), with 
significant decrease of bacterial burden (Fig. 6C and fig. S9B) com-
pared to vehicle. Differently, both KB-R7943 and vehicle-treated WT 
mice survived to infection and did not show differences in bacterial 
clearance (Fig. 6B) or bacterial burden (Fig. 6C and fig. S9B). These 
results show that KB-R7943 impacts on a better health status and 
P. aeruginosa infection in CFTR-KO mice.
Lung histopathology and the degree of inflammation were in-
vestigated by scoring global inflammatory response, extension, and 
type in tissue sections of murine lungs stained with hematoxylin 
and eosin (H&E) (Fig. 6, D and E, and fig. S8, C and D). In CFTR-KO 
and, in part, in WT mice, P. aeruginosa infection favored the diffu-
sion of a massive exudate in lungs (Fig. 6D, I and VII), with a large 
involvement of alveolar spaces and broncho-bronchiolar lumina 
that markedly reduced the aerate areas (Fig. 6D, II, III, VIII, and IX). 
KB-R7943 treatment reduced the inflammatory status in CFTR-KO 
lungs. A marked reduction of the inflammatory cells in alveoli and 
deep airways was documented (Fig. 6D, IV, V, VI, X, XI, and XII) in 
KB-R7943–treated mice compared to vehicle. Moreover, P. aeruginosa 
infection significantly increased histological inflammation scores, 
which were diminished when the animals were pretreated with 
KB-R7943 (Fig. 6E and fig. S9, C and D).
In vivo, the pretreatment with KB-R7943 in CFTR-KO mice re-
duced NLRP3 inflammasome expression in the lung homogenates 
after infection to levels detected in ctrl WT mice, thus preventing 
the P. aeruginosa–triggered NLRP3 inflammasome priming observed 
in vehicle-treated CFTR-KO mice (Fig. 6F). In line with the data 
in vitro, the higher LC3-II/LC3-I ratio in KB-R7943–treated CFTR-KO 
mice than in vehicle-treated CFTR-KO mice confirmed the recovery 
of autophagy in vivo (Fig. 6F).
Last, the efficacy of KB-R7943 on the exacerbated P. aeruginosa–
triggered inflammation in CF was confirmed by the reduced IL-1 
and IL-18 levels detected in BALF of treated CFTR-KO mice 
(Fig. 6G). Conversely, no significant differences in inflammatory 
cells and tumor necrosis factor– (TNF) levels between KB-R7943 
and vehicle-treated mice were detected (fig. S9, E and F), suggesting 
that the “first proinflammatory signal,” or Toll-like receptor signaling, 
in both lungs is unchanged with the drug treatment. The reduction 
of released cytokines in BALF is due to rectified autophagy and 
escaped P. aeruginosa–dependent mitochondrial dysfunction, avoiding 
thus abnormal UPRmt and NLRP3 inflammasome activation in 
KB-R7943–treated CFTR-KO mice.
DISCUSSION
The excessive inflammatory response due to chronic airway infec-
tion by P. aeruginosa plays a critical role in the CF lung pathology 
and disease progression. Within the innovative CF therapy pipeline, 
including CFTR “correctors” and “potentiators,” effective and alter-
native anti-inflammatory drugs are lacking. CFTR correctors and 
potentiators have garnered much attention in the CF community, 
although their impact on downstream consequences, such as in-
flammation, has been debated. Evidence shows that P. aeruginosa 
burden decreased in the first 6 months of modulator therapy but 
rebounded thereafter, increasing the inflammatory response (36).
A number of bacterial pathogens perturb mitochondrial func-
tion to promote proliferation and infection, such as P. aeruginosa. 
Conversely, mitochondria present different roles in resistance against 
bacterial infection, including mitochondrial ROS production and 
inflammasome activation (37, 38), and protective roles, such as 
mitophagy and UPRmt (8, 39).
Previous data showed that CFTR-defective bronchial cells have 
increased intracellular [Ca2+] associated to increased susceptibility 
to pathogen-dependent mitochondrial dysfunction (7). The perturbed 
Ca2+ homeostasis in patients with CF underlies the compromising 
mechanisms of mitochondrial stress response and quality control 
pathways. The prolonged and abnormal UPRmt activation is the 
negative consequence of the down-regulation of selective autophagic 
response in CF, which leads to an increase in pathogen survival, 
resulting in enhanced innate immune and mitochondrial-protective 
gene expression (40) and, ultimately, worsen pulmonary inflamma-
tion (Fig. 3).
During infection, the interactions between ER and mitochondria 
change to sustain a range of physiological processes. This structural 
perturbation is proposed to represent a physiological response of 
the cell to altered mitochondrial bioenergetics during infection be-
cause mitochondria require Ca2+ for efficient production of ATP 
(41). ER-mitochondria interactions arise as a result of ER-resident 
VAPB closely associated with mitochondrial protein PTPIP51, 
enabling ER membrane recruitment to mitochondria. Here, we re-
ported that P. aeruginosa–induced VAPB-PTPIP51 tether regulates 
autophagy in CF bronchial cells. The increase of VAPB and PTPIP51 
expression triggered by bacterial infection in CF bronchial cells 
induces tightening of the tether and concomitant impairment of 
autophagy (Figs. 1 and 2). We also demonstrated that blocking the 
ER-mitochondria Ca2+ exchange via MCU-targeted short hairpin 
RNA (shRNA) or pharmacological inhibition, by KB-R7943, abro-
gates the effects of VAPB and PTPIP51 on autophagy in CF cells 
during bacterial infection (Figs. 4 and 5). Our findings are in line with 
a large number of studies that show that perturbation of Ca2+ delivery 
to mitochondria stimulates autophagy and mitophagy (11, 42, 43).
Our discoveries about the regulation of mitophagy and UPRmt in 
CF during P. aeruginosa infection have suggested a therapeutic 
strategy to promote the overall health of the mitochondrial network 
to limit the CF lung disease progression and bacterial infection. 
Consistent with the ability of KB-R7943 to reduce CF pulmonary 
inflammation, the promotion of autophagy appeared to contribute 
to the protective activity of KB-R7943.
Our findings qualify KB-R7943 as a mitochondrial Ca2+ regula-
tor that rectifies unbalanced autophagic activity controlling UPRmt 
and NLRP3 inflammasome activation, known to contribute significantly 
to pathologic airway inflammation in CF (7). The cross-regulation 
between autophagy and inflammasomes may also explain the ability 
of KB-R7943 to limit P. aeruginosa–triggered NLRP3 inflammasome 
priming in the lungs of CFTR-KO mice in vivo (Fig. 6) (44, 45).
According to our study, mitochondrial Ca2+ regulators have 
emerged as a new option for CF therapy in controlling inflamma-
tion and bacterial infection. Currently, there are two specific MCU 









Rimessi et al., Sci. Adv. 2020; 6 : eaax9093     6 May 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
13 of 17
impermeable to the PM (20). In 2017, a high-throughput assay that 
screened for human MCU-specific small-molecule modulators identi-
fied mitoxantrone as selective inhibitor of MCU among more than 
600 clinically approved drugs. Unfortunately, mitoxantrone was 
toxic after 48 hours of treatment, independent of its action on MCU 
(46). Despite mechanistic limitations and the availability of newer, 
more selective MCU inhibitors, KB-R7943 is the first available MCU 
inhibitor, which is freely permeable through the PM, with protective 
activity (31). KB-R7943, which was developed to inhibit the reverse 
mode of NCX in intact cells (47), has been shown to protect against 
myocardial ischemia-reperfusion injury and neuronal damage 
(34, 48, 49). The effect of KB-R7943 is about threefold more selec-
tive for NCX3 than for NCX1 and NCX2 (50), and NCX3 is the only 
isoform that is also located on the outer mitochondrial membrane 
involved in the regulation of mitochondrial Ca2+ homeostasis (51).
The mechanism through which KB-R7943 confers protection 
remains controversial and debated. If used at concentrations up to 1 M, 
KB-R7943 may inhibit a variety of ion channels (Na+, K+, and Ca2+), 
neurotransmitters receptors (nicotinic and N-methyl-d- aspartate), 
and store-operated Ca2+ entry (52). In the kidney, KB-R7943 in-
creases renal vascular resistance, causing vasoconstriction that may 
be harmful (53), and is toxic to cancer cells at high concentrations 
(30 M and more) by inducing apoptosis and affecting autophagy 
(54). The nonspecificity of the molecule and its toxicity at high con-
centrations have long limited the clinical usefulness of KB-R7943. 
Nevertheless, it remains an important pharmacological tool in the 
laboratory setting to define and develop new therapeutic approaches.
Here, we show that KB-R7943 is endowed with unique activity 
to correct CF pulmonary physiopathology through the regulation of 
autophagy and inflammation. Although KB-R7943 appears to play 
roles in multiple activities through which it may rectify P. aeruginosa–
triggered autophagy and preserve mitochondrial homeostasis, inhi-
bition of mitochondrial Ca2+ signaling appears to be a key to these 
mechanisms, as well as considering that the CF bronchial cells used 
for in vitro experiments lack any PM NCX activity (32).
Through its multitasking activity, KB-R7943 treatment could 
represent viable strategy to rectify the multifunctional defect in in-
dividuals with CF. Airway epithelia absorb Na+ through the epithe-
lial Na+ channel (ENaC), which is negatively regulated by CFTR. In 
patients with CF, the absence of CFTR results in an ENaC hyper-
activity and increased Na+ absorption (55). This increase results in 
membrane depolarization that activates the NCX reverse mode, 
promoting a further influx of Ca2+ in CF cells (56). Intracellular 
Ca2+ overload provides a positive feedback loop for autophagy and 
chloride secretion inhibition and mitochondrial dysfunction 
(13, 57–60). This indicates that KB-R7943 could be exploited in 
CF for pharmacologic correction of outcomes related to (i) intra-
cellular Ca2+ overload through inhibition of PM NCX reverse mode 
and (ii) mitochondrial Ca2+ overload through the simultaneous 
inhibition of MCU and NCX3 reverse mode. In this view, KB-R7943 
represents an excellent example of a multitasking drug with anti- 
inflammatory effects that can also favor rescuing of chloride secretion 
and CFTR functioning in patient with CF, ameliorating airways disease.
METHODS
Antibodies and other reagents
For immunoblot and immunostaining, the following antibodies 
were used:
anti-actin (A3853), anti-LC3 (L7543), and anti–-tubulin (T5201; 
all from Sigma-Aldrich); anti-MCU (ab121499), anti-myc (ab9106), 
anti-ATF5 (ab60126), anti-pseudomonas (ab68538), anti-VAPB 
(ab196487), anti-PTPIP51 (ab224081), and anti-VDAC (ab15895; 
all from Abcam); anti-GFP (sc9996), anti–hemagglutinin (HA) 
(sc7392), anti-HSP60 (sc13115), anti-mitofusin 2 (MFN2) (sc50331), 
and anti- HSP10 (sc20958; all from Santa Cruz Biotechnology); anti- 
CLPP (14181), anti-ATF4 (11815), anti–glyceraldehyde-3-phosphate 
dehydrogenase (2118), anti–IL-1 (12242), and anti-NDP52 (9036; 
all from Cell Signaling Technology); anti-optineurin (10837-1-AP, 
ProteinTech); anti–caspase-1 (NB100-56565, Novus Biologicals); 
anti-NLRP3 (ag20boo14, AdipoGen); and anti-IP3R3 (BD Biosciences). 
All the reagents were from Sigma-Aldrich, unless otherwise indicated. 
KB-R7943 (sc202681) was dissolved in dimethyl sulfoxide and was 
from Santa Cruz Biotechnology.
Cell culture, transfection, and infection
IB3-1 cells (CF cells) are human bronchial epithelial cells derived 
from patient with CF with a mutant F508/W1282X genotype. The 
CF phenotype of the IB3-1 cells was corrected in the S9 cell line 
(non-CF cells; non-CF) by transfection with WT adeno-associated 
virus expressing CFTR. Both cells were grown on plastic support 
under liquid-liquid conditions in LHC-8 basal medium (Life Tech-
nologies) supplemented with 5% fetal bovine serum.
CuFi-1 (CF cells) and NuLi cells (non-CF) were a gift from 
J. Zabner (University of Iowa). The CuFi-1 cells were derived from 
human bronchial epithelia from a patient with CF (CFTR mutant 
genotype F508/F508), and the NuLi cells were derived from the 
normal lung of a 36-year-old patient. These cells were grown 
under liquid-liquid conditions on human placental collagen- 
coated flasks (Sigma-Aldrich) with bronchial epithelial growth 
medium (Lonza).
The CF patient–derived cells are represented by polarized 
mucociliary-differentiated human airway epithelium that was recon-
stituted in vitro using cells isolated from patient (MucilAir Epithelix 
CF-202; a 24-year-old female with homozygous F508/F508) and grown 
on Transwell air-liquid interface. The wt CFTR human primary cells 
are represented by polarized mucociliary-differentiated human air-
way epithelium that was reconstituted in vitro with cells isolated 
from donor (MucilAir Epithelix; MD-801, a 59-year-old female 
donor with no pathology reported) and grown on Transwell air- 
liquid interface.
Stable MCU-silencing IB3-1 cell clone was obtained using shRNA 
targeting MCU (TRCN0000133861) purchased from Sigma-Aldrich. 
IB3-1 cells were cultured in tissue dish to 75% of confluence and 
infected with lentiviral-driven shRNA targeting MCU for 48 hours. 
The infected cells were selected by the addition of 5 M puromycin 
to the culture medium, fed every 2 to 3 days with selection medium, 
and checked for cell death after 3 to 7 days. Resistant cells were nor-
mally observed after about 2 weeks of selection. Individual cells were 
selected randomly and placed in separate wells within a 24-well 
plate. Clones were grown to confluency and expanded in a mainte-
nance puromycin media (0.5 M). Expanded clones were retested 
for MCU expression before any further studies. Primary Nlrp3+/+ 
and Nlrp3−/− MEFs were cultured in Dulbecco’s Modified Eagle 
Medium supplemented with 10% fetal bovine serum (Life Technol-
ogies) and 1% penicillin-streptomycin-glutamine (100×) liquid.
For the transient overexpression experiments, pNEO plasmid 
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cloned in pEGFP-N1 were transfected with Lipofectamine LTX 
(Life Technologies) according to the manufacturer’s recommendations. 
After 36 hours, the transfected cells were infected with the well- 
characterized, motile, nonmucoid P. aeruginosa laboratory strains, 
named PAO1, donated by A. Prince (Columbia University). Bacterial 
colonies from overnight cultures on trypticase soy agar (Difco) 
plates were grown in 20 ml of trypticase soy broth (Difco) at 37°C 
with shaking until an optical density (OD660nm) corresponding to 
1 × 107 CFU/ml was reached. The bacteria were washed twice with 
Krebs-Ringer buffer (KRB), and diluted in each specific serum-free 
medium before infection. PAO1 was added to cells as indicated in 
the captions for Figs. 1 through 5. 
Mucopurulent material was harvested from the lumens of ex-
cised human CF lungs infected with P. aeruginosa at the UNC Adult 
Cystic Fibrosis Center. SMM from several patients was pooled to 
assure homogeneous stimulus throughout the experiments. Ten micro-
liters of SMM (1:100) or KRB (a control for SMM) was applied to 
cells for 6 hours.
Proximity ligation assay
PLAs to quantify IP3R3-VDAC interactions were performed in 
according to the manufacturer’s protocol of Duolink reagents (Sigma- 
Aldrich). Cells were fixed in 4% paraformaldehyde in KRB and 
probed with mouse IP3R3 (BD Biosciences) and rabbit anti-VDAC1 
(Abcam) antibodies. Signals were developed using a Duolink In Situ 
Far Red kit. Images were acquired with digital imaging system based 
on a Zeiss Axiovert 200 fluorescence microscope (20× objective) and 
quantified using ImageJ.
Immunoblotting
Briefly, to obtain whole-cell extracts, cells were washed, harvested, 
and lysed in radioimmunoprecipitation assay buffer supplemented 
with 2 mM Na3VO4, 2 mM NaF, 1 mM phenylmethylsulfonyl 
fluoride, and complete protease inhibitor cocktail (Roche Diag-
nostics Corp.).
Thereafter, protein extracts were separated on precast 4 to 12% 
SDS–polyacrylamide gel electrophoresis gels (Life Technologies), 
electrotransferred onto polyvinylidene difluoride membranes (Bio-
Rad), and probed with the specific antibodies. Last, the membranes 
were incubated with the appropriate horseradish peroxidase–
conjugated secondary antibodies (SouthernBiotech), followed by 
chemiluminescence detection using West Pico reagent (Thermo 
Scientific Pierce). The immunoreactive bands were acquired using 
the ImageQuant LAS-4000 system (GE Healthcare) and quantified 
using ImageJ. The immunoblots shown are representative of at least 
three independent experiments.
Immunofluorescence
After infection, the cells were washed with KBR and fixed in 4% 
paraformaldehyde for 10 min. Then, cells were permeabilized for 
10 min with 0.1% Triton X-100 in KBR and blocked in KBR contain-
ing 2% bovine serum albumin and 0.05% Triton X-100 for 1 hour. 
Cells were then incubated with primary antibody overnight at 4°C 
and washed three times with KBR. The appropriate isotype-matched, 
Alexa Fluor–conjugated secondary antibodies (Life Technologies) 
were used. Images were taken with a Nikon Swept Field confocal 
equipped with CFI Plan Apo VC60XH objective [numerical aperture 
(NA), 1.4] (Nikon Instruments) and an Andor DU885 electron multi-
plying charge-coupled device camera (Andor Technology Ltd.).
Ca2+ measurements
For cytosolic aequorin and mitochondrial aequorin measurements, 
cells growing on coverslips were incubated with 5 M coelenterazine 
for 2 hours in KRB supplemented with 1% fetal calf serum and then 
transferred to the perfusion chamber. To reconstitute the aequorin 
chimeras targeted to the ER, the luminal [Ca2+] of this compart-
ment had to be first reduced by incubating the cells for 1 hour at 4°C 
in KRB supplemented with 5 M ionomycin and 600 M EGTA in 
the presence of 5 M coelenterazine, followed by extensive washing 
of the cells with KRB supplemented with 2% BSA and 1 mM EGTA. 
All aequorin measurements were performed in KRB supple-
mented with 1 mM CaCl2, and agonists and other drugs were 
added to the same medium, as specified in the figure legends. 
Experiments terminated by lysing the cells with 100 M digi-
tonin in a hypotonic, Ca2+-rich solution to discharge the re-
maining aequorin pool. The output of the discriminator was 
captured by a Thorn EMI photon counting board and stored in 
an IBM-compatible computer for further analyses. The aequorin 
luminescence data were calibrated offline into [Ca2+] values 
using a computer algorithm based on the Ca2+ response curve of 
WT and mutant aequorins.
Microscopy analysis
For autophagic and mitophagic count, the cells were seeded and 
then transfected with LC3 in pEGFP-C1 and Parkin cherry, respec-
tively. After 36 hours, images were taken on a Zeiss Axiovert 200 
fluorescence microscope (63×, 40×, or 20× objectives). For each 
condition, the number of GFP-LC3 or Parkin cherry–clustering 
cells was counted in at least 10 to 20 independent visual fields and 
expressed as percentage. For colocalization analysis, the cells were 
seeded and then cotransfected with mtRFP and GFP-LC3 or mtGFP 
and Parkin cherry using Lipofectamine LTX. After 36 hours, coverslips 
were placed in an incubated chamber with controlled temperature, 
CO2, and humidity, and z stacks at 21 planes and a distance of 0.2 m 
were taken to allow acquisition of the entire cell. The images were 
restored with the AutoQuant three-dimensional blind deconvolution 
module and loaded into Imaris 4.0 (Bitplane AG). Obtained puncta 
images were merged to compare the GFP signals with RFP or cherry 
signals using ImageJ software. For each condition, the colocalization 
of these two signals was quantified in at least 20 independent visual 
fields, expressing the data as number of LC3 or Parkin dots localized 
to mitochondria/cell.
Subcellular fractionation
After infection, the cells (109) were harvested, washed two times 
with KBR, resuspended in homogenization buffer [225 mM mannitol, 
75 mM sucrose, 30 mM tris-HCl (pH 7.4), 0.1 mM EGTA, and 
phenylmethylsulfonyl fluoride], and gently disrupted by Dounce 
homogenization. The homogenate was centrifuged twice at 600g for 
5 min to remove nuclei and unbroken cells. The supernatant was 
then centrifuged at 10,300g for 10 min to pellet crude mitochondria. 
The crude mitochondrial fraction was resuspended in isolation buffer 
[250 mM mannitol, 5 mM Hepes (pH 7.4), and 0.5 mM EGTA] and 
then subjected to Percoll gradient centrifugation [Percoll medium: 
225 mM mannitol, 25 mM Hepes (pH 7.4), 1 mM EGTA, and 30% 
(v/v) Percoll]. After centrifugation at 95,000g for 30 min (SW40 
rotor), a dense band containing purified mitochondria was collected, 
washed by centrifugation at 6300g for 10 min to remove the Percoll, 
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Bacterial clearance
Bacterial killing was performed infecting human airway epithelial 
cell with GFP-expressing P. aeruginosa strains (ampicillin resistant 
strains) at different multiplicities of infection (MOIs). Briefly, the 
cells were infected in serum-free LHC-8 media with ampicillin- 
resistant P. aeruginosa strain at an MOI of 1:10 and 1:100 for 6 hours. 
Extracellular bacteria were killed with cell-impermeable antibiotics 
[penicillin-streptomycin (50 U/ml each; Life Technologies) and 
gentamycin (200 g/ml; Life Technologies)]. Cells were then washed 
in KBR and lysed in KBR containing 0.2% Triton X-100 (Sigma- 
Aldrich), and a serial dilution of lysate was streaked in duplicate on 
ampicillin-selected LB (lysogeny broth) agar plates and incubated over-
night at 37°C. The day after, CFUs were counted. Samples containing 
no cells were used to identify background CFUs, which were subtracted 
from samples.
Bacterial invasion
Double bacteria labeling, confocal microscopy, and image analysis 
allow identification and quantification of the number of internal-
ized bacteria. To identify intracellular and extracellular bacteria, 
images from whole cells were analyzed in three steps. First, a binary 
mask of the P. aeruginosa antibody channel (594 nm) highlighting 
extracellular bacteria was generated. Then, the mask was subtracted 
from the bacterial channel (GFP-expressing P. aeruginosa strains; 
488 nm), giving intracellular bacteria as a result. Last, the logical 
AND operation was performed between the mask and the bacterial 
channel, giving extracellular bacteria as a result. Images of patho-
logical and non-CF cells infected with GFP-expressing P. aeruginosa 
and stained with anti–P. aeruginosa antibody were acquired. All 
data are expressed as ratio between the 488- and 594-nm signal.
ROS production measurements
Mitochondrial ROS production was measured by staining cells in 
KBR for 15 min at room temperature with 5 M MitoSox Red 
(Life Technologies) and successively analyzed on a Tali image-based 
cytometer (Life Technologies).
Mitochondrial membrane potential measurements
Cells were loaded with 10 nM tetramethylrhodamine methyl ester 
(TMRM) (Life Technologies) at 37°C for 20 min, placed in a humidified 
chamber, and imaged with a LiveScan Swept Field Confocal Microscope 
(Nikon Instruments Inc.) equipped with a 60× oil immersion lens. 
To completely collapse, the electrical gradient established by respira-
tory chain FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone; 
10 M) was added. All data are expressed as percentage of the total 
TMRM fluorescence minus the TMRM fluorescence after FCCP 
treatment.
Mitochondrial targeted GCaMP6m measurements
To test [Ca2+]m with high sensitivity, a Ca2+ probe based on the 
last-generation GCaMP probe was generated, targeted to the mito-
chondrial matrix. We chose the GCaMP6m version due to its highest 
Ca2+ affinity (Kd of 167 nM). To be truly quantitative, we took ad-
vantage of the isosbestic point in the GCaMP6m excitation spectrum, 
in living cells exciting GCaMP6m at 400 nm leads to fluorescence 
emission, which is not Ca2+ dependent.
S9 and IB3-1 cells were grown on 24-mm coverslips and trans-
fected with mtGCaMP6m-encoding plasmid. After 36 hours, cover-
slips were placed in one ml of modified KRB (5.5 mM glucose and 
1 mM CaCl2), and imaging was performed on an Olympus Xcellence 
widefield system equipped with a 40×/1.3 NA Oil Plan Fluor objec-
tive. Excitation was performed at 490 and 400 nm, and one field was 
collected per coverslip. Images were captured each 500 ms, and 
after the first 50 frames, PAO-1 (MOI of 100) or SMM (MOI of 1:100) 
was added to cells as indicated in the figure. Analysis was performed 
with ImageJ where both images were background and corrected 
frame by frame. The data are presented as the means ± SE of the 
ratio of all time points of all the experiments, using Prism (GraphPad 
Prism, USA), and we have calculated the area under curve for each 
experiments.
Cell viability assay
Cells were plated in 60-mm plates and pretreated with 1 M KB-
R7943 for 1 hour before PAO1 infection. Cells were harvested 
72 hours after treatment and stained using annexin V Alexa Fluor 
488/propidium iodide, as described by a Tali apoptosis kit (Life 
Technologies). Cell viability was evaluated using the Tali image- 
based cytometer (Life Technologies). The annexin V–positive cells 
were recognized as dead cells by the cytometer software and ex-
pressed as percentage of cellular death.
Subjects and housing
Animals used in all procedures were 10- to 19-week-old gut- 
corrected CFTR-deficient male C57BL/6 Cftrtm1UNCTgN(FABPCFTR) 
#Jaw mice (CFTR-KO) and their WT littermates. All mice were 
maintained under specific pathogen–free conditions in sterile cages, 
which were put into a ventilated isolator. Fluorescent lights were cycled 
12 hours on and 12 hours off, and ambient temperature (23° ± 1°C) 
and relative humidity (40 to 60%) were regulated. Mice were fed with 
irradiated 5K-52 rodent chow (Safe, France) and autoclaved tap water.
Mouse model of chronic infection and  
lung histological analysis
For the infection procedure, P. aeruginosa AA43 strain isolated 
from a patient with CF before death was embedded in agar beads. 
Mice were anesthetized to implant into the lung an inoculum of 50 l 
of agar bead suspension, embedding 1.5 × 106 CFU of AA43 strain.
Mice were treated with KB-R7943 (300 g/kg) or vehicle via 
aerosol administration by Penn-Century MicroSprayer Aerosolizer 
every 12 hours starting 1 hour before infection. Two days after in-
fection (1 hour after last treatment), mice were sacrificed to collect 
BALF and lungs for histopathological analysis. A detailed descrip-
tion of all the procedures used is reported in Supplementary Materials 
and Methods section.
Mass spectrometry
All the quantitative analysis of KB-R 7943 were performed using a 
Xevo TQD mass spectrometry instruments (Waters, USA) equipped 
with a Acquity ultraperformance liquid chromatography system with 
a BEH (ethylene bridged hybrid) C18 column using a linear gradient of 
water and acetonitrile with 0.1% of formic acid.
Cytokines assay
Airway epithelial cells were plated in six-well plates and left unin-
fected, pretreated with the selective inhibitor of caspase-1 [20 M; 
30 min before infection or KB-R7943 (1 M) 1 hour before infec-
tion], and primed with bacteria (MOI of 100) for 6 hours at 37°C. IL-1, 
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BALF were measured using an R&D Systems or an MBL enzyme- 
linked immunosorbent assay kit, respectively.
Statistical analysis and ethics statement
Unless otherwise indicated, all assays were performed independently 
and in triplicate, yielding comparable results. The data, which are 
presented as the means ± SE, were analyzed using Microsoft Excel 
(Microsoft Co.), and statistical significance was determined by 
Student’s t tests and analysis of variance (ANOVA). Statistical analysis 
was performed with Prism (GraphPad Prism, USA) and Microsoft 
Excel (Microsoft Co). **P < 0.01 and *P < 0.05 were considered sta-
tistically significant.
This study was carried out according to protocols approved by 
San Raffaele Scientific Institute (Milan, Italy) Institutional Animal 
Care and Use Committee, in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals of 
the Italian Ministry of Health. The experimental protocol has been 
approved by the Italian Ministry of Health (protocol number 733).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/19/eaax9093/DC1
View/request a protocol for this paper from Bio-protocol.
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Supplementary figure 1: Defective CFTR channel favors ER-mitochondria interaction during 
pathogen infection in CF bronchial cells. 
A) The bar chart shows quantification of PLA signals (%) for IP3R3 and VDAC interactions (I) in 
S9 (non-CF) and IB3-1 (CF) cells exposed to supernatant from mucopurulent material from CF 
patients (SMM); (II) in NuLi (non-CF) and CuFi (CF) cells infected with PAO1 at 100 MOI for 6 
hours. The bar chart shows quantification of PLA signals (%), respect to uninfected non-CF cells 
(n=25-35 independent visual field for each condition of three independent experiments). B) 
Immunoblots show ER-mitochondria Ca
2+
 exchange proteins and tethers expression in S9 (non-CF) 
and IB3-1 (CF) cells during P. aeruginosa infection. The samples were probed using the antibodies 
indicated, where actin and -tubulin are used as loading control. C) Western blot quantification, 
expressed as the ratio of VAPB/actin (I) and PTPIP51/actin (II), of the blot in figure 1B, as 
previously described (n=5-6 of independent experiments). D) (I) Immunoblots show VAPB and 
PTPIP51 expression in NuLi (non-CF) and CuFi (CF) cells during P. aeruginosa infection. The 
cells were uninfected or infected with PAO1 at 100 MOI for three, six and twelve hours. The 
samples were probed using the antibodies indicated, where GAPDH is used as loading control. 
Protein molecular mass markers are indicated in kD. (II) Bar chart shows the ratio LC3-II/LC3-I, 
(III) the ratio of VAPB/GAPDH and (IV) PTPIP51/GAPDH following quantification of signals 
from immunoblots (n=3); (V) Immunoblots show ER-mitochondria Ca
2+
 exchange proteins and 
tethers expression in NuLi (non-CF) and CuFi (CF) cells during P. aeruginosa infection. The 
samples were probed using the antibodies indicated, where actin is used as loading control. E) (I) 
Immunoblots show VAPB and PTPIP51 expression in polarized mucociliary-differentiated donor-
derived airway cells (MD-801, non-CF) and ΔF508/F508 patient-derived airway cells (CF-202, 
CF) during P. aeruginosa infection. The cells were uninfected or infected with PAO1 at 100 MOI 
for six hours. The samples were probed using the antibodies indicated, where GAPDH is used as 
loading control. Protein molecular mass markers are indicated in kD. (II) Bar chart shows the ratio 
of LC3-II/LC3-I, (III) of VAPB/GAPDH and (IV) of PTPIP51/GAPDH following quantification of 
signals from immunoblots (n=3); (V) Immunoblots show ER-mitochondria Ca
2+
 exchange proteins 
and tethers expression in polarized mucociliary-differentiated donor-derived airway cells (MD-801, 
non-CF) and ΔF508/F508 patient-derived airway cells (CF-202, CF) during P. aeruginosa 
infection. The samples were probed using the antibodies indicated, where actin is used as loading 


































Supplementary figure 2: The downregulation of autophagy in CF bronchial cells is the 
consequence of the enhanced ER-mitochondria interaction during P. aeruginosa. 
A) Confocal immunofluorescence images of IB3-1 cells cotransfected with Myc-VAPB and Ha-
PTPIP51. The cells were probed using respectively Myc-tag and Ha-tag primary antibodies. 
Colocalization of VAPB and PTPIP51 signal during PAO1 (100 MOI) or SMM (1:100) exposition 
was performed and expressed as the % of colocalization, which was calculated as average volume 
of the overlapping areas (n=8 independent visual field for each condition). B) NuLi (non-CF) and 
CuFi (CF) cells were infected with PAO1 at 100 MOI for 6 hours and then treated with either 
vehicle or bafilomycin A1 (100nM) as indicated. (I) The samples were probed on immunoblots for 
LC3 and GAPDH as a loading control. (II) Bar chart shows the ratio LC3-II/LC3-I following 
quantification of signals from immunoblots (n=6). C) Polarized mucociliary-differentiated donor-
derived airway cells (MD-801, non-CF) and ΔF508/F508 patient-derived airway cells (CF-202, 
CF) were infected with PAO1 at 100 MOI for 6 hours and then treated with either vehicle or 
bafilomycin A1 (100nM) as indicated. (I) The samples were probed on immunoblots for LC3 and 
GAPDH as a loading control. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification 





Supplementary figure 3: Defective CFTR channel lead to down regulation of xenophagy and 
mitophagy in CF bronchial cells. 
A) Western blot quantification of mitophagic markers in mitochondrial fraction, expressed as the 
ratio of (I) Optineurin/VDAC, (II) NDP52/VDAC and (III) LC3-II/LC3-I of the blot in figure 2A, 
as previously described (n=4 of independent experiments). B) P. aeruginosa-infected (I) NuLi 
(non-CF) and CuFi (CF) cells or (II) Polarized mucociliary-differentiated donor-derived airway 
cells (MD-801, non-CF) and ΔF508/F508 patient-derived airway cells (CF-202, CF) were lysed 
after the addition of impermeable antibiotics and streaked on LB agar plates for the determination 
of intracellular CFUs (n=6 of independent experiments). C) Measurements of ΔΨ in S9 (non-CF) 
and IB3-1 (CF) cells after 6 hours of bacterial infection. The bars show the change in TMRM 
fluorescence level, expressed as % change with respect to S9 uninfected cells. FCCP was used to 
collapse the mitochondrial ΔΨ (n=12-20 of independent experiments). F.a.u., fluorescent arbitrary 
units. D) Effects of P. aeruginosa infection on mitochondrial superoxide production in S9 and IB3-
1 cells. The quantification of % change of cells positive for MitoSox staining is shown (n=5-8 of 






Supplementary figure 4: Defective CFTR channel lead a persistent activation of UPR
mt
 in CF 
bronchial cells during pathogen infection. 
A) Representative confocal images of nuclear translocation of endogenous ATF5 (I) and ATF4 (II) 
in NuLi (non-CF) and CuFi (CF) cells during pathogen infection. The graphs report the nuclear 
redistribution of ATF5 and ATF4 after PAO1 infection, expressed as percentage increase in 
fluorescent ratio signals (from cytosol to nucleus) with respect to uninfected condition (n=15 
independent visual field for each condition of three independent experiments). B) Western blot 
quantification of UPR
mt
 markers, expressed as the ratio of CLPP/actin, HSP60/actin, HSP10/actin, 
ATF4/actin and ATF5 dimer/actin of the blot in figure 3B, as previously described (n=3 of 
independent experiments). C) Immunoblots of CuFi and NuLi cells uninfected or infected for three, 
six and twelve hours, as indicated. The samples were probed using the antibodies indicated, related 
to UPR
mt
 markers, where actin is used as loading control. Bar chart reports western blot 
quantification of UPR
mt
 markers, expressed as the ratio of CLPP/actin, HSP60/actin, HSP10/actin, 
ATF4/actin and ATF5 dimer/actin (n=4 of independent experiments). D) Immunoblots of polarized 
mucociliary-differentiated ΔF508/F508 patient-derived airway cells (CF-202, CF) and donor-
derived airway cells (MD-801, non-CF) uninfected or infected for six hours. The samples were 
probed using the antibodies indicated, related to UPR
mt
 markers, where actin is used as loading 
control. Bar chart reports western blot quantification of UPR
mt
 markers, expressed as the ratio of 
CLPP/actin, HSP60/actin, HSP10/actin, ATF4/actin and ATF5 dimer/actin (n=3 of independent 
experiments). t-Test used for indicated comparisons (* p<0.05 and ** p<0.01). 
 
Supplementary figure 5: ATF5 potentiates the autophagic defect and the inflammasome 
response in CF bronchial cells during pathogen infection.   
A) The IB3-1 cells (CF) were transfected with GFP- and ATF5GFP and then infected with PAO1 at 
100 MOI for six hours and successively treated with bafilomycin A1, as reported for figure 3C. The 
samples were probed using the antibodies indicated, where GAPDH is used as loading control. B) 
(I) Autophagic flux in CuFi cells (CF) overexpressing ATF5 during P. aeruginosa infection. GFP- 
and ATF5GFP-transfected cells were infected with PAO1 at 100 MOI for six hours and then treated 
with bafilomycin A1, as indicated. (II) Bar chart shows the ratio LC3-II/LC3-I following 
quantification of signals from immunoblots (n=4). C) Immunoblots of cleaved caspase-1 and 
processed IL-1 from lysates (lys) or supernatants (sur) of CuFi and ATF5-overexpressed CuFi 
cells infected for 6 hours with P. aeruginosa. Actin was used as loading control. The quantification 
is expressed as the ratio of casp1-p10/actin and IL-1 cl./actin. The bars are the means±SE of three 
independent immunoblots. D) Effects of ATF5 overexpression on the IL-1 (I) and IL-18 (II) 
release. NuLi (non-CF) and CuFi (CF) cells were transfected with ATF5-GFP and after 6 hours of 
PAO1 infection, the cultured cell supernatant were collected to quantify the levels of 
proinflammatory cytokines (n=8 of independent experiments). The selective inhibitor of caspase-1, 
Ac-YVAD-cmk 20M, was added thirty minutes before infection. E) (I) Autophagic flux in 
untreated and Ac-YVAD-cmk-treated IB3-1 cells (CF) overexpressing ATF5 during P. aeruginosa 
infection. GFP- and ATF5GFP-transfected cells were pre-treated with Ac-YVAD-cmk 20M thirty 
minutes before infection with PAO1 at 100 MOI for six hours and successively treated with 
bafilomycin A1, as indicated. (II) Bar chart shows the ratio LC3-II/LC3-I following quantification 
of signals from immunoblots (n=4). F) Nigericin (10M, thirty minutes before infection) treatment 
in IB3-1 cells affected the bacterial clearance of P. aeruginosa. Nigericin-treated and untreated IB3-
1 cells were lysed after the addition of impermeable antibiotics and streaked on LB agar plates for 
the determination of intracellular P. aeruginosa CFUs (n=8 of independent experiments). t-Test 








































Supplementary figure 6: The silencing of MCU prevents the increase in ER-mitochondria 
interaction and the UPR
mt
 activation in CF bronchial cells exposed to pathogen. 
A) VAPB or PTPIP51 overexpression increases the IP3R3-VDAC interactions in IB3-1 cells. The 
bar chart shows quantification of PLA signals (%) respect to uninfected mock IB3-1 cells (n=15 
independent visual field for each condition of three independent experiments). B) Histamine-
dependent mitochondrial Ca
2+ 
responses of mock-, VAPB- and PTPIP51-overexpressing IB3-1 (I) 
and CuFi (II) cells; (C) Histamine-dependent cytosolic Ca
2+ 
responses of mock-, VAPB- and 
PTPIP51-overexpressing IB3-1 cells. The histograms show the mean±SE of mitochondrial and 
cytosolic Ca
2+
 responses (n=10-15 of independent experiments). D) The bar chart shows 
quantification of PLA signals (%) for IP3R3 and VDAC interactions in MCU-silenced (IB3-1 
shMCU) and IB3-1 cells challenged with SMM. Stable MCU-silenced CF clone was transfected 
with control empty vector (mock), VAPB, or PTPIP51, then exposed to SMM (1:100) for 6 hours 
(n=15 independent visual field for each condition of three independent experiments). E) 
Endogenous level of MCU expression in stable MCU-silenced and IB3-1 cells. Cell lysates were 
immunoblotted with anti-MCU and anti- tubulin as loading control. F) Representative 
measurements of histamine-induced mitochondrial Ca
2+
 response in MCU-silenced and IB3-1 cells. 
Cells were transfected with mitochondrial-targeted aequorin and stimulated with 100M histamine 
to induce ER-mitochondria Ca
2+
 transfer. G) TMRM fluorescent measurements in MCU-silenced 
(shMCU) and IB3-1 cells in resting condition. The histograms show the % change of ΔΨ in MCU-
silenced IB3-1 cells compared to mock IB3-1 cells (n=12 of independent experiments). H) 
Representative confocal images of nuclear translocation of endogenous ATF5 (I) and ATF4 (II) in 
IB3-1 (mock) and MCU-silenced IB3-1 (shMCU) cells during pathogen infection. The graphs 
report the nuclear redistribution of ATF5 and ATF4 after PAO1 infection, expressed as percentage 
increase in fluorescent ratio signals (from cytosol to nucleus) with respect to uninfected condition 
(n=15 independent visual field for each condition of three independent experiments). t-Test used for 





































Supplementary figure 7: KB-R7943 prevents mitochondrial Ca
2+
 overload and inflammasome 
activation in CF bronchial cells during pathogen infection. 
A) Immunoblots of cleaved caspase-1 and processed IL-1 from lysates (lys) or supernatants (sur) 
of IB3-1 and ATF5-overexpressed IB3-1 cells, previously pretreated with MCU-inhibitor, KB-
R7943 (1M) for one hour then infected for 6 hours with P. aeruginosa. Actin was used as loading 
control. The quantification is expressed as the ratio of casp1-p10/actin and IL-1 cl./actin. The bars 
are the means±SE of four independent immunoblots. B) Effects of the pretreatment with KB-R7943 
(1M) on the levels of released IL-1β and IL-18 in mock and ATF5-overexpressing CuFi cells, 
collected after 6 hours of PAO1 infection at 100 MOI (n=8 of independent experiments). C) 
Histamine-dependent mitochondrial Ca
2+
 responses of KB-R7943 pretreating CuFi cells at different 
time points. The histograms show all mean±SE of mitochondrial Ca
2+
 responses (n=8 of 
independent experiments). D) No changes in histamine-induced cytosolic Ca
2+
 response (I) and 
intraluminal ER Ca
2+
 content (II) in IB3-1 cells exposed to MCU-inhibitor at different time points, 
as indicated. Before exposition, the cells were transfected with native and ER-targeted aequorin. 
The histograms show the mean value±SE (n=12-15 of independent experiments). E) Histamine-
induced cytosolic Ca
2+
 response in IB3-1 cells treated with KB-R7943 and PAO1 at 100 MOI. F) 
Mitochondrial Ca
2+
 dynamics in S9 (non-CF), IB3-1 (CF) and KB-R7943-treated IB3-1 (CF-KB-
R7943) cells exposed to SMM, evaluated through ratiometric imaging of mitochondrial targeted 
GCaMP6. Traces represent mean±SE of mitochondrial Ca
2+
 response from at least of 10 
independent experiments. SE values are illustrated using grey shading. For statistical significance 
the Multiple t-Test has been used. The bar chart shows the quantification of the area under the 












































Supplementary figure 8: KB-R7943 confers cell resistance to pathogen infection restoring 
xenophagy in CF bronchial cells during P. aeruginosa infection. 
A) Effects of KB-R7943 on the autophagy in CuFi cells during pathogen infection. (I) The samples 
were probed on immunoblots for LC3 and actin as a loading control. (II) Bar chart shows the ratio 
LC3-II/LC3-I following quantification of signals from immunoblots (n=3). B) Effects of KB-R7943 
on the xenophagy in CuFi cells (I) and in polarized primary patient-derived CF-202 cells (II). CF 
cells were pretreated with KB-R7943 one hour before infection with PAO1 at 100 MOI for 6 hours, 
then lysed after the addition of impermeable antibiotics and streaked on LB agar plates for the 
determination of intracellular CFUs (n=6 of independent experiments). (C) Effect of KB-R7943 on 
CF bronchial cell apoptosis, during P. aeruginosa infection, using annexin-V Alexa Fluor® 488/PI 
staining. Cell viability and death were evaluated using the Tali™ apoptosis kit and the Tali™ 
Image-based Cytometer. Bars show the percentage of CuFi and CF-202 (CF) and NuLi and MD-81 
(non-CF) cells, respectively, that were annexin V–FITC positive (n=4 independent experiments). D) 
Bacteria were growth, in trypticase soy agar added with KB-R7943 at different concentration, at 
37°C with shaking at 200 rpm and the OD660 values were monitored each two hours. The reported 











Supplementary figure 9: KB-R7943 mitigates the P. aeruginosa-triggered inflammatory 
response in CF mice without affecting the total number of inflammatory cells. 
A) Representative mass spectrum of KB-R7943 detected in plasma of WT (I) and CFTR-KO mice 
(II). B) Bacterial burden in BALF of KB-R7943-treated and untreated mice after two days from 
P. aeruginosa challenge is shown. The bars represent mean±SE of lung CFU in mice. Data were 
analyzed by two-way ANOVA and Tukey’s post hoc test (* p<0.05, n=15-20 mice analyzed of 
three independent experiments). C) Graphs summarize histological scoring of inflammatory 
extension (n=60 of independent experiments) and D) Inflammatory type grading based on H&E 
staining (n=45 of independent experiments). Data were analyzed by t-Test used for indicated 
comparisons and by two-way ANOVA and Tukey’s post hoc test (* p<0.05 and ** p<0.01). E) The 
number of total leukocytes and in particular of neutrophils and macrophages in the airways were 
analyzed in BALF from WT and CFTR-KO mice after two days of lung infection and pretreated 
with KB-R7943 (300 g/kg). The horizontal and vertical lines represent mean±SE values (n=12 of 
independent experiments). F) Levels of TNF in BALF from WT and CFTR-KO mice exposed to 
P. aeruginosa infection, treated with KB-R7943 (300 g/kg) and vehicle, expressed as mean ±SE 





Supplementary Material and Methods: 
Mouse model of chronic infection and treatment  
For the infection procedure, P. aeruginosa AA43 strain isolated from a CF patient before death, was 
embedded in agar-beads as previously described (1). Mice were anesthetized by an intraperitoneal 
injection of a solution of Avertin (2,2,2-tribromethanol, 97%) in 0.9% NaCl and administered at a 
volume of 0.015 ml/g body weight. Mice were placed in supine position. The trachea was directly 
visualized by ventral midline, exposed and intubated with a sterile, flexible 22-g cannula attached to 
a 1 ml syringe. An inoculum of 50l of agar bead suspension, embedding 1.5x10
6
 CFU of AA43 
strain, was implanted via the cannula into the lung. After inoculation, all incisions were closed by 
suture. Mice were treated with KB-R7943 (300µg/kg) or vehicle via aerosol administration by 
Penn-Century MicroSprayer® Aerosolizer every 12 hours starting one hour before infection. Two 
days post-infection (one hour post last treatment), mice were sacrificed. BALF was extracted with a 
22-gauge venous catheter by washing the lungs with RPMI-1640 (Euroclone) with protease 
inhibitors (Complete tablets, Roche Diagnostic and PMSF, Sigma). An aliquot of BALF was 
serially diluted and plated on trypticase soy agar (TSA, Becton Dickinson). Total cells present in 
the BALF were counted, and a differential cell count was performed on cytospins stained with Diff 
Quick (Dade, Biomap, Italy). BALF was then centrifuged and supernatant tested for cytokines 
levels. Lungs were excised aseptically and homogenized in 2 ml PBS with protease inhibitor using 
the homogenizer gentleMACS
TM
 Octo Dissociator and dilutions spotted onto TSA plates and CFU 
determined after overnight growth at 37°C.   
Mice were monitored twice per day for the piloerection, attitude, locomotion, breathing, curiosity, 
nasal secretion, grooming and dehydration. Mice that lost >20% body weight and had evidence of 
severe clinical disease, such as scruffy coat, inactivity, loss of appetite, poor locomotion, or painful 
posture, were sacrificed before the termination of the experiments with an overdose of carbon 
dioxide. 
 
Lung histological analysis 
In another group of mice, lungs were excised aseptically, fixed in formalin, and embedded in 
paraffin. Consecutive sections from the middle of the five lung lobes were stained by hematoxylin 
and eosin, examined using an Axioplan fluorescence microscope (Zeiss), and images were taken 
with a KS 300 imaging system (Kontron). Sections were blindly examined and scored by a 
pathologist. Histological score analysis of murine lungs was performed to: i) evaluate in a general 
manner the percentage of lung’s parenchyma involvement in the inflammatory/infiltration process; 
ii) evaluate the distribution of inflammatory infiltrate between the aerate spaces and/or interstitial 
areas; iii) grade the amount of innate immune cells infiltration and BALT activation. Regarding the 
first two evaluations i), and ii) lung’s sections were observed and scored at a magnification of ×100. 
For iii) evaluations, the assessment of cellular infiltrates and aggregation was obtained by scoring 
the number of immune cells (mononuclear cells, such as macrophages, lymphocytes, plasma cells, 
and neutrophils) at a magnification of ×400. The number of inflammatory cells was evaluated by 
using a visual analogue scale modified for murine pulmonary specimens, as described previously 
(2), and results are reported as the average for the entire specimen. When considerable 
heterogeneity of infiltration was evident in the same specimen, the mean for several areas was 
determined and the specimen was scored accordingly. Neutrophils and macrophages were classified 
as absent (score of 0) when there were no or fewer than 19 cells per high-power field (HPF) (at a 
magnification of ×400), mild (score of 1) for 20 to 49 cells per HPF, moderate (score of 2) for 50 to 
99 cells per HPF, marked or severe (score of 3) for 100 to 200 cells or more per HPFs. Histological 
criteria for normal pulmonary characteristics included detection of no or only a few mononuclear 
cells per HPF and no or only a few scattered neutrophils in bronchioli and alveoli without tissue 
changes (no interstitial thickening or aggregates of lymphocytic infiltrates, and airways free from 
exudate). The number of inflammatory cells and of lymphoid aggregates, assessed at ×400 and 
×100 magnification respectively, was scored and customized as previously described (3). 
Histologic lesions of the respiratory bronchial epithelium were evaluated and scored for the 
presence or absence of ciliated columnar cells, goblet cells, edema, hyperplasia or metaplasia of 
epithelial cells, and lymphocytes infiltration (see also the scoring system to evaluate adaptive 
immunity), based on the previously described scoring system (4): presence of ciliated columnar 
epithelium, normal goblet cells, and no lymphocyte infiltration in respiratory epithelium (score 1); 
presence of focal lesions, some degenerative or necrotic epithelial cells, small focal areas lacking 
cilia, no lymphocyte infiltration in respiratory epithelium (score 2); multifocal areas lacking cilia 
accompanied by edema, degenerative and hyperplastic changes in epithelial cells, locally disrupted 
epithelial layer, infiltration of lymphocytes (score 3); diffuse or severe lesions showing replacement 
of normal ciliated columnar epithelial lining by the squamous to cuboidal epithelium without cilia, 
disrupted epithelial layer in many places, depletion of goblet cells, and infiltration of lymphocytes 
into respiratory epithelium (score 4). The sums of scores of bronchial lesions for mouse in one 
group were summed, and was used for statistical comparison of the severity lesions between the 
groups. Finally, concerning histological scores indicating an adaptive immune response, the 
presence of lymphoid nodules consisting of 5 to 7 lymphocyte-like cells (germinal centers) within 
areas of secondary bronchi and blood vessels, the intensity of dispersed lymphocyte infiltration in 
the interalveolar septa and interparabronchial septum and around the secondary bronchi as well as 
around the blood vessels was evaluated and recorded. The score was calculated as follow: no 
lymphocyte accumulation in interalveolar and interparabronchial septa, and very few germinal 
centers around secondary bronchi and blood vessels (score 0); accumulation of a few dispersed 
lymphocytes without the increase of the number of germinal centers (score1); moderate 
accumulation of lymphocytes in interalveolar and interparabronchial septa, increased size of 
germinal centers (group of 10–13 cells) around blood vessels (score 2); thickened interatrial septa in 
a large area of the lung, interparabronchial septa infiltrated with histiocytes and lymphocytes, and 
increased number of germinal centers (score 3). The sum of scores of the mice in one group was 
used for statistical comparison of the severity of bronchial lesions and mononuclear cells system 
activation between the groups. For BALT activation, the score was assessed at ×100, by calculating 
the total areas of BALT follicles evaluated inside each lung section, and subdividing the mean as 
follow: mean area of BALT follicle extension none (score 0); up to 0.008 square mm (score 1); up 
to 0.042 square mm (score 2); up to 0.4 square mm (score 3). For evaluation the degree of 
interstitial thickening and edema in lungs, sections were assessed evaluating the degree of 
interstitial eosinophilia, amorphous and hyaline aspect, with intersperse and not well-organized 
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